View
1.347
Download
10
Tags:
Embed Size (px)
DESCRIPTION
A CLINICAL STUDY ON THE MANAGEMENT OF TAMAKA SHWASA WITH SPECIAL REFERENCE TO VIRECHANA AND SHAMANA, Sujata .S.Tenginakai, PG Studies in Kayachikitsa, A.L.N. Rao Memorial Ayurvedic Medical College and P. G. Centre, Koppa.
Citation preview
BY Dr. SUJATA .S.TENGINAKAI
BAMS (Karnataka University, Dharward)
DISSERTATION SUBMITTED TO THE
RAJIV GANDHI UNIVERSITY OF HEALTHSCIENCES, KARNATAKA, BANGALORE IN PARTIAL FULFILLMENT
OF THE REQUIREMENTS FOR THE DEGREE OF “DOCTOR OF MEDICINE” (AYURVEDA)
in
KAYACHIKITSA
GUIDE Prof. P.K.MISHRA
MD (Ay)., (RSU).,
H.O.D of KAYACHIKITSA
DEPARTMENT OF POST GRADUATE STUDIES IN KAYACHIKITSA A.L.N.RAO MEMORIAL AYURVEDIC MEDICAL COLLEGE KOPPA - 577126
CHIKMAGALUR DISTRICT, KARNATAKA, INDIA MARCH - 2004
A.L.N.Rao Memorial Ayurvedic Medical College Koppa – 577126 Dist: Chikmagalur
Department of Post graduate Studies in KAYACHIKITSA
I here by declare that this dissertation entitled “A CLINICAL STUDY ON THE
MANAGEMENT OF TAMAKA SHWASA WITH SPECIAL REFERENCE TO
VIRECHANA AND SHAMANA” is a bonafide and genuine research work
carried out by me under the guidance of Prof. P.K.MISHRA.
H.O.D of Post Graduate Studies in KAYACHIKITSA, A.L.N. Rao Memorial
Ayurvedic Medical College P. G. Centre, Koppa.
Date:
Place: Koppa
Dr. Sujata .S.Tenginakai P.G.Schalor,
Dept. of Kayachikitsa, A.L.N. Rao Memorial Ayurvedic Medical College, Koppa – 577 126
A.L.N.Rao Memorial Ayurvedic Medical College Koppa – 577126 Dist: Chikmagalur
Department of Post graduate Studies in KAYACHIKITSA
This is to certify that the dissertation entitled “A CLINICAL STUDY ON THE
MANAGEMENT OF TAMAKA SHWASA WITH SPECIAL REFERENCE TO
VIRECHANA AND SHAMANA” is a bonafide research work done by
Dr. Sujata .S.Tenginakai. in partial fulfillment of the requirement for
the degree of Ayurveda Vachaspati (MD) in Kayachikitsa of Rajiv Gandhi
University of Health Sciences, Bangalore, Karnataka.
Date:
Place: Koppa
Prof. P.K.MISHRA MD (Ay)., (RSU).,
Head of the Department, Kayachikista
A.L.N.Rao Memorial Ayurvedic Medical College.
Koppa –577126, Dist: Chikmagalur
A.L.N.Rao Memorial Ayurvedic Medical College Koppa – 577126 Dist: Chikmagalur
Department of Post graduate Studies in KAYACHIKITSA
This is to certify that the dissertation entitled “A CLINICAL STUDY ON THE
MANAGEMENT OF TAMAKA SHWASA WITH SPECIAL REFERENCE TO
VIRECHANA AND SHAMANA” is a bonafide research work done
by Dr. Sujata. S.Tenginakai. of under the guidance of
Prof. P.K.MISHRA. H.O.D of Post Graduate Studies in
Kayachikitsa A.L.N. Rao Memorial Ayurvedic Medical College P. G. Centre,
Koppa.
Date:
Place: Koppa
Dr.Jagadeesh.Kunjal. MD (Ayu).,
Principal, A.L.N.Rao Memorial Ayurvedic Medical College. Koppa –577126, Dist: Chikmagalur
COPYRIGHT
I here by declare that the Rajiv Gandhi University of Health Sciences,
Karnataka shall have the rights to preserve, use and disseminate this
dissertation in print or electronic format for academic/research purpose.
Date:
Place:
Dr. Sujata .S.Tenginakai. P.G.Schalor, Dept. of Kayachikitsa, A.L.N. Rao Memorial Ayurvedic Medical College, Koppa – 577 126
© Rajiv Gandhi University of Health Sciences, Karnataka
ACKNOWLEDGEMENT
I remain grateful forever to respective Guide Prof.P.K.Mishra. M.D (Ayu)., HOD,
Dept. of Kayachikitsa, A.L.N.Rao Ayurvedic Medical College Koppa, for his valuable
guidance, meticulous supervision, timely given advises, motivational inspiration and co-
operation that he extended kindly towards me throughout this dissertation work.
I am grateful for ever indebted to Sri Aroor Ramesh Rao, President, A.L.N.Rao
Ayurvedic Medical College Koppa, for giving me an opportunity to do my P.G.Studies.
I am grateful to Dr.Jagadeesh Kunjal M.D (Ayu), Principal, A.L.N.Rao Ayurvedic
Medical College Koppa, for his help and support in completing this work.
My sincere gratitude to Prof.D.S.Lucas, M.D (Ayu), FRAS (London), for his
motivational inspiration and support.
My sincere gratitude to Dr.Sanjaya K.S., M.D (Ayu)., Dept. of Dravya guna,
A.L.N.Rao Ayurvedic Medical College Koppa, for his timely guidance and moral
support.
My sincere gratitude to Prof.Narayan Sharma M.D., Dept. of Kayachikista,
Dr.Prashanth .A.S, Asst.Prof. Dept. of Kayachikitsa, Hubli, Dr.Dinesh Mishra M.D,
Dept. of Rasashastra, Dr.Sreedhar .V, Dr.Lalitha Bhaskar, Dr.Das, Dr.Poornima,
Dr.Manasa for their guidance and advises.
My special thanks to Dr.Anandalakshmi, Tutor, Dept. of Shareerakriya,
Trivendrum for her kind and valuable help.
My special thanks to Dr.Rahul, Lecturer, Bagalokot, Dr.Aparaj, Dr.Ramesh N.V,
Dr.Shanubag.
I am grateful to Mr.Satish, Librarian and Miss.Triveni who helped me a lot in my
reference work.
I express my sincere gratitude to Prof.Narayan Tantri, Dept. of Statistics
Bandakar’s College Kundapur who assisted in the statistical analysis of my dissertation
work.
I am equally grateful to Mr. Ramesh Gowda, Smt.Jyothi, and all office staff. My
special thanks to Miss.Jyotsa, Lab technician, Mr.Thomas and all hospital staff.
I am especially thankful to Mr.Mathew, Miss.Vimala of college pharmacy for
their timely help while preparing the medicine.
My special thanks to Miss.Nandini, Mr.Bhavesh of Panchakarma Department for
their help in giving Bahyabhyanga and Nadisweda to the patients. And also to Nurses
Miss.Manjula, Miss.Lalita, Miss.Sunitha who took care of patients during their
admission.
I grateful to my electronic crew Mr.Shrikanth Shetty and Mr.Shreedhar Gowda of
Koppa for their kind support during typing, editing and printing of this dissertation work.
I special to thanks to my friends Dr.Indu, Dr.Pradeep, Dr.Pankaj, Dr.Pratibha, and
Dr.Kavitha for their help in completing the dissertation work.
My special thanks to U.G.Students Mr.Raghavedra, Mr.Srinivas, Mr.Srinath for
their help in arranging the matter.
I would like to submit my heartfelt thanks to all my patients who participate in my
study took the medicine with the great faith.
I remain grateful forever to my brother and sisters who offered me great moral
support in my P.G.Studies. I am heartly grateful to my loving husband Dr.M.S.Koppad,
M.B.B.S., who inspired me and helping me to pursue the master degree and his friend
Dr.Sanjay Patil, M.D. General Medicine, who helped in the collection of modern literature
and gave guidance.
I dedicate this work to my parents who helped me financially and in all aspect.
Finally a thank all who helped directly or indirectly to complete this work I wish
to acknowledge the please.
Dr.Sujata. S.Tenginakai.
ABBREVATION
Cha.Sa.Su – Charaka Samhita Sutrasthana
Cha.Sa.Ni - Charaka Samhita Nidansthana
Cha.Sa.Chi – Charaka Samhita Chikitsasthana
Cha.Sa.K – Charaka Samhita Kalpasthana
Cha.Sa.Ind - Charaka Samhita Indriyasthana
Cha.Sa.Si - Charaka Samhita Siddhisthana
Su.Sa.Su – Shusruta Samhita Sutrasthana
Su.Sa.Chi – Shusruta Samhita Chikitsasthana
Su.Sa.U – Shusruta Samhita Uttaratantra
A.H.Su – Astanga Hridaya Sutrasthana
A.H.Ni – Astanga Hridaya Nidanasthana
A.H.Chi - Astanga Hridaya Chikitsasthana
A.S.Su – Astanga Sangraha Sutrasthana
A.S.Ni - Astanga Sangraha Nidanasthana
Sha.Sa.P.K – Sharangadhar Samhita Prathama Khanda
Sha. Sa.M.K - Sharangadhar Samhita Madhyma Khanda
Sha.Sa.U.K - Sharangadhar Samhita Uttara Khanda
Y.R.Swa.Chi – Yoga Ratnakara Swasa Chikitsa
B.R. – Bhishajya Ratnavali.
Ma.Ni – Madhava Nidana.
Ha.Sa. – Harita Samhita
B.P.Ni.H.V – Bhavaprakasha Nighantuadhyaya Haritakyadi Varga
B.P.Ni.G.V - Bhavaprakasha Nighantuadhyaya Guduchyadi Varga
A.P of India – Ayurvedic Pharmacopoeia of India
INDEX
Page No.
INTRODUCTION 1-2
Chatper – I OBJECTIVES 3
Chapter – II REVIEW OF LITERATURE
Historical Review 4-5
Nirukti 6
Nidana 7-9
Samprapti 10-13
Poorvarupa 14
Rupa 15-17
Upashaya Anupashaya 18
Upadrava Arista, Sadhya Sadhyata 19
Vyavachedaka Nidana 20
Chikitsa vivechana 21-24
Pathya Apathya 25-26
Concept of Virechana 27-32
Modern Review 33-38
Drug Review 39-44
Chapter –III METHODOLOGY 45-52
Chapter –IV RESULTS 53-93
Chapter –V DISCUSSION 94-110
Chapter –V CONCLUSION 111-112
SUMMARY 113
REFERENCES
BIBLIOGRAPHY
CLINICAL PROFORMA
LIST OF TABLES
Page No.
1) Nidana of Shwasa/Tamaka shwasa 7-9
2) Poorvarupa of shwasa roga. 14
3) Lakshanas of Tamaka shwasa 15-16
4) Vyavachedaka nidana 20
5) Pathya in Tamaka shwasa 25
6) Apathya in Tamaka shwasa 26
7) Samsarjana karma in Tamaka shwasa 32
8) Symptom dairy 49-50
9) Grading for assessment of severity of Tamaka shwasa 51
10) Distribution of patients according to age group. 53
11) Distribution of patients according to sex. 54
12) Distribution of patients according to economic status 54
13) Distribution of patients according to education 55
14) Distribution of patients according to food habits 56
15) Distribution of patients according to agni 56
16) Distribution of patients according to prakrati 57
17) Distribution of patients according to koshta 58
18) Distribution of patients according to satwa 58
19) Distribution of patients according to habitat 59
20) Distribution of patients according to chronicity 60
21) Distribution of patients according to relation to food 60
22) Distribution of patients according to sleep pattern 61
23) Distribution of patients according to relation to exercise 62
24) Distribution of patients according to relation to climate 62
25) Distribution of patients according to relation to smoking 63
26) The response of therapies after treatment. 69-70
27) The response of therapies at the end of follow up. 78
28) Statistical analysis of group A results 84
29) Statistical analysis of group B results 85
30) Statistical analysis of group C results 86
31) Observations based on laboratory findings. 93
LIST OF DIAGRAMS, CHARTS & GRAPHS
Page No.
A. List of diagrams
1. Fig No 1 – Incidence of Age. 53
2. Fig No 2- Incidence of sex 54
3. Fig No 3 - Incidence of Economical status 55
4. Fig No 4 - Incidence of Education 55
5. Fig No 5 - Incidence of food habits 56
6. Fig No 6 - Incidence of Agni 57
7. Fig No 7 - Incidence of Prakruti 57
8. Fig No 8 - Incidence of Koshta 58
9. Fig No 9 - Incidence of Satwa 59
10. Fig No 10 - Incidence of Habitat 59
11. Fig No 11 - Incidence of Chronicity 60
12. Fig No 12 - Incidence Relation to food 61
13. Fig No 13 - Incidence of Sleep pattern 61
14. Fig No 14 - Incidence Relation to Exercise 62
15. Fig No 15 - Incidence Relation to Climate 63
16. Fig No 16 - Incidence of smoking 63
B. List of Charts
17. Flow Chart showing Samprapti of Tamaka Swasa 11
C. List of Graphs
1. Overall response at the end of treatment 70
2. Response on Shwasakrichrata at the end of treatment 71
3. Response on Ghurghuraka at the end of treatment 71
4. Response on Kasa at the end of treatment 72
5. Response on Shwasakrichrata (Duration) at the end of treatment 72
6. Response on Nidra at the end of treatment 73
7. Response on Prajna at the end of treatment 73
8. Response on Shwasakrichrata (speech) at the end of treatment 74
9. Response on Vyavyama at the end of treatment 74
10. Response on PEFR at the end of treatment 75
11. Overall response at the end of follow up. 79
12. Response on Shwasakrichrata at the end of follow up 79
13. Response on Ghurghuraka at the end of follow up 80
14. Response on Kasa at the end of follow up 80
15. Response on Shwasakrichrata (Duration) at the end of follow up 81
16. Response on Nidra at the end of follow up 81
17. Response on Prajna at the end of follow up 82
18. Response on Shwasakrichrata (Speech) at the end of follow up 82
19. Response on Vyayama at the end of follow up 83
20. Response on PEFR at the end of follow up 83
21. Mean scores of Shwaskrichrata in A, B & C groups. 87
22. Mean scores of Ghurghuraka in A, B & C groups. 87
23. Mean scores of Kasa in A, B & C groups. 88
24. Mean scores of Shwaskrichrata(Duration) in A, B & C groups. 88
25. Mean scores of Nidra in A, B & C groups. 89
26. Mean scores of Prajna in A, B & C groups. 89
27. Mean scores of Shwaskrichrata (Speech) in A, B & C groups. 90
28. Mean scores of Vyayama in A, B & C groups. 90
29. Mean scores of PFERin A, B & C groups. 91
30. Mean scores of Overall response in A, B & C groups. 91
ABSTRACT
Tamaka Shwasa the disease of pranavaha srotas is said to be sadhya in its initial
stage of onset provided that it is accurately diagnosed and treated properly, otherwise it
becomes yapya. It is prevalent in almost all parts of the world.
Tamaka shwasa is vatakaphaj vyadhi being pittasthana samudhbhava, Virechana
has been considered effective therapy. In the same way Acharya Charaka mentioned the
importance of shamana therapy, also opines ‘Tamaketu Virechanaam’ hence it is the need
of time to find out effective therapy for this dreadful disease.
Objective :-
1. To evaluate the effect of Virechana and Bharangyadi kwatha in bringing
symptomatic relief.
2. To find out effect of the treatment on the lung functions
Methods :-
In this clinical study 36 patients were selected for the study (6 patients left in
between) coming under inclusive criteria and are randomly allocated into three groups
For Group A – Virechana
Group B – Bharangyadi kwatha
Group C – Virechana followed by Bharangyadi kwatha has been given.
Severity of disease was assessed by subjective and objective parameters.
Interpretation and Results:
Group A has greater significant effect on PEFR, Shwasakrichrata (speech) and
Prajna at the end of follow up and significant effect on vyayama at the end of follow up,
non significant effect on Shwasakrichrata, Kasa, Nidra. Group B has highly significant
effect on Shwasakrichrata (duration), Shwasakricrta (speech) PEFR, Group C has overall
highly significance. Thus Virechana improves vital capacity of lungs, effort based
activities, whereas Bharangyadi kwatha relieves air way obstruction as well as improves
vital capacity of lungs and effort based activities.
Conclusion:
• Virechana helps in enhancing vital capacity of lungs effort based activities.
• Virechana acts as Vatanulomaka, Raktashodaka, Shonita sthapaka and has little effect
on air way obstruction.
• Bharangyadi kwatha has better effect on both air way obstruction, effort based
activities.
Keywords:
Pittasthana; PEFR; Tamaka shwasa; Virechana; Bharangyadi kwatha; Shamana;
Shwasakrichrata; Prajna; Raktashodaka; Shonita sthapaka;
Introduction
Page 1
INTRODUCTION
¦ddeªd±¤dZ §d‚dPd§d®d¦dZ ±§dmßd Umµ£I¶«d¬dd¦£dT«dŠ | I¶PMµdÙeUµe®d‰e¦dSdd‰£d §dd£dga e®d°Pdg§dQd«dm£d«dŠ | §df£®dd Ÿdd«©dT§dfSdj°da §dg¦dTdSde£d ®dy›d£dZ || §d‚fPdSd¦QyUµ«dešd¬da ¡df®dSd¢¡dMµTd¦d¬d«dŠ ||
¯dTfT§d‚dPdSddyTy®d ±daSddy›ddQdSdgèŸSd£dy || 1
Thus respiration is the vital sign of life, its normalcy indicates the health; its
abnormality suggests disease and ceasation marks death. This unique indicator of life is
affected in the disease Tamaka shwasa 2. Any illness in person enforces him to be
restricted to bed. But in Tamaka shwasa patient is made to prop up instead of lying on the
bed 3. Rest for Tamaka shwasa patient is not on the bed but on the chair. Two mirrors
facing each other produces infinite numbers of images, like wise the patient of
Tamakashwasa living in the hostile environment suffers from frequent and innumerable
attacks of shwasa. Pre existing khavaigunya or reduced Vyadhi Kshamatva is said to be
the reason for abnormal response of the patient towards the trivial changes in the
environment which behaves as enemy of the patient. During an asthma attack it is
actually harder to breath out than it is breath in.
Tamaka shwasa which may be considered as Bronchial Asthma with the parlance
of modern medical science has a high incidence as 5-10% of the population are suffering
from Bronchial Asthma with irrespective of age, sex, occupation and socioeconomic
status etc in the present day. Even though with the best possible measures for the
management of Tamaka shwasa; the incidence of the disease is markedly increasing.
Hence it is the need of the time to ascertain an effective management of Tamaka shwasa.
The word ‘Asthma’ is a derivation of Greek word, meaning panting or gasping.
The word remains as we have no better word to describe it. Difficulty in breathing
whenever present cannot be called as Asthma. The prefix bronchial specifies the fact that
the basic problem is in the tracheobronchial tree, with the growing knowledge about
asthma, this condition is clearly defined and differentiated from other breathlessness.
Introduction
Page 2
In Ayurvedic science more emphasis is laid on the Shodhana upakramas as
Apunarbhava chikitsa. In the context of Tamaka shwasa. It is seen that more importance
is given to virechana i.e. Tamaketu virechanam 4.
Classically the concept of virechana in Tamaka shwasa seems quite encouraging
as virechana is vatanulomaka, chikitsa for pittasthana, pittasthanagata kapha and for
kapha samsristha doshas 5. All of the above concepts hypothetically indicates virechana
as a concept modality of treatment of Tamak shwasa, by restoring the normal flow of
vata, relieving the obstruction, the augmenting the normal functions of the pittasthana,
the seat of origin and expelling the morbid humors.
Bharangyadi kwathaa 6, 7 on the other hand possess all the properties, which can
mitigate the morbid doshas, facilitating normal flow of vata by reliving the obstruction.
Considering long term, effect of virechana and a short duration management by
Bharangyadi kwatha encouraged to under take the present study to clinically asses the
efficacies of the either of therapies considering the classical background.
The present dissertation work entitled – ‘A Clinical Study on the effect of
Virechana and Bharangyadi kwatha in Tamakashwasa with special reference to Bronchial
Asthma consists of following chapters.
objectives
Review of Literature
Methodology
Results
Followed by Discussion, Conclusion and Summary.
Objectives
� Page 3
OBJECTIVES
1) To evaluate the efficacy of virechana and Bharangyadi kwatha in bringing
symptomatic relief.
2) To find out the effect of therapies on lung functions.
3) Evaluating the role of Shamana and Shodhana chikitsa over the Tamaka shwasa by
following three group of studies.
a. Shamana chikitsa of Bharangyadi kwatha
b. Shodhana chikitsa of Virechana
c. Shodhana followed by Shamana chikitsa
4) To establish the utmost the utility of Bharangi over Tamaka shwasa on using
clerodendrom serratum roots under shamana group of studies.
5) Finding the benefit of purificatory therapy as virechana over Tamaka shwasa
according to major classical treaties of Ayurveda.
6) Analysing the subjective parameters of the disease Tamaka shwasa according to the
contemporary classical literature.
7) To find out the mode action of drug sample over the Tamaka shwasa as
Bronchodilator or with any other specific action.
8) To establish a safest and economically, easily feasible drug sample over Tamaka
shwasa.
Review of Literature
A. DISESE REVIEW
HISTORICAL REVIEW
PREVEDIC AND VEDIC PERIOD
Reference regarding Tamaka shwasa is not available in the Vedic scripts, there is
only reference regarding the Prana vata and Apana vata available in Vedic scripts.
UPANISHATH KALA
Reference of respiration, opinion of absence of respiration suggesting the death is
available Amanaskopanishath.
In Brhadaranyakopanishath, Chandogyopanishath Prana has been named as
Angeeras, Ayusha, Brahaspati.
In Yoga Chudamanyam, the diseased conditions of Pranavaha srotas which
includes Hikka, shwasa and Kasa are described.
SAMHITA PERIOD
Charaka Samhita:
Detail descriptions regarding the Nidana Samprapti, Lakshanas, Sadhyasadhyatva
and Chikitsa have been explained in Charaka Samhita chikitsa sthana 17th chapter.
Sushruta Samhita:
The entire description of Shwasa roga is Nidanadi treatment is available in
Sushruta Samhita 51st chapter of Uttaratantra.
Bhela Samhita:
Shwasa as a symptom is mentioned in Bhela Samhita. In the form of complication
of many disorders shwasa is described in this treatise.
Page 4
Review of Literature
Harita Samhita:
Nidana Chikitsa Pathyapathya of shwasa roga are described in Harita Samhita in
its 14th chapter of third sthana.
Kashyapa samhita:
The brief description of shwasa roga, and its treatment is described along with
Kasa roga in Khila sthana.
Astanga Hridaya and Astanga Sangraha:
In both Nidana and Chikitsa sthana, description of shwasa is available.
Madhava Nidana:
In this book diagnostic aspect of shwasa roga is described in the 12th chapter.
MEDIEVAL PERIOD
Chakrapanidatta:
Description of shwasa roga available in this book is in accordance with
Brihatrayi.
Chakradatta:
His treatise describe shwasa chikitsa in the 12th chapter along with Hikka roga.
Arunadatta:
In his commentary “Sarvangasundara on Astanga Hridaya, he has mentioned the
involvement of Kapha Dosha in the Etiopathogenesis of shwasa roga.
Bhavaprakasha and Yogaratnakara:
Nidanas and Chikitsa of Tamaka shwasa have been explained in Bhavaprakasha
Madhyama khanda 4 chapter and also in Shwasa Chikitsa Adhyaya by Yogaratnakara.
Bharangyadi kwatha is mentioned by Yogaratnakara for Tamaka shwasa.
Page 5
Review of Literature
NIRUKTI
[ETYMOLOGICAL DERIVATION]
In Ayurveda, criteria for naming of the disease is not uniform. The diseases
Raktapitta and Vatarakta are named after the Dosha and Dushya involved in their
Samprapti. Grahani is named considering the site of illness. Cardinal symptom of illness
is the criteria for naming diseases like Chardi and Atisara. Likewise the predominant
symptom breathlessness is the basis for naming the disease shwasa. The word Tamaka
shwasa consists of two words. They are Tamaka and Shwasa.
TAMAKA
“Tamyati Anena Iti Tamaka, Tamaka Glanou” per this Sanskrit derivation, the
word Tamaka means, to choke darkness, be suffocated (VS Apte dictionary).
‘Tamyati Iti Tamaka, Tama Eva Tama’ in Shabdakalpadruma, according to this
the illness that causes darkness or the illness itself is the darkness is called by the name
Tamaka.
SHWASA
The word Shwasa is defined from the Sanskrit root shwasa, meaning “to breathe”.
“Shwasati Anena Iti Shwasaha” – breathing of air is known as shwasa (Apte dictionary).
This derivation represents the physiological aspect of breathing.
“Shwasasthu Basthrikadhmana Vatordwagamitha” – as per this derivation word
shwasa refers to expiration of the air producing sound similar to the one generated while
blowing the air with a blower by the blacksmith. This refers to the forceful laboured
breathing, probably with wheezing sound, thus it unravels the pathological expression of
breathing.
TAMAKA SHWASA
‘Tamakascha Asoushwasacha Tamaka Shwasa’ – this line explains manifestations
of the difficulty in breathing which occurs mainly during the night time.
“Visheshyaddurdine tammyethi Shwasaha Sa tamaka mataha”. The attack of
shwasa with tamapravesha which occurs specially during durdina is called Tamaka
shwasa.
Page 6
Review of Literature
NIDANA
“Setikartavyataha rogatpadakaheturnidanam”8. The causative factor that
aggravates the doshas produces the diseases is called Nidana.
The causative factors of Shwasa roga which is of five types in general are also the
etiological factors of Tamaka shwasa. Tamaka shwasa may develop as an independent
illness, as a result of exposure to specific vata and kapha vitiating factors.
The disease may also manifest as a sequel of certain disorders like Anaha,
Raktapitta. Here Tamaka shwasa manifests as Nidanarthakara roga 9. To be more precise,
the illness Tamaka shwasa may be,
1.Nidanottha : the resultant of specific incriminatory factors
2. Rogottha : a sequel of certain disease 10, 11.
Chakrapani commenting on the nidanas (explained by Charaka) has classified
them into the Vataprakopaka gana and Kaphaprakopaka gana suggesting the rest of
nidanas as Viprakristha karanas.
Etiologies mentioned in Modern science are seen to resemble with nidanas
explained by our classics.
Table No.1 Showing Samanya nidanas of Tamaka shwasa
AAHARA SAMBANDHI
No CS12 SS13 AS14 AH15 BP16 YR17 MN18
1 Abhishyandi Bhojana + + - - + + + 2 Amaksheera + - - - - - - 3 Anoopa Mamsa + - - - - - - 4 Apatarpana + + - - + + + 5 Dadhi + - - - - - - 6 Guru Bhojana + + - - + + + 7 Jalaja Mamsa + - - - - - - 8 Masha + - - - - - - 9 Nishpava + - - - - - - 10 Pinyaka + - - - - - - 11 Pistha + - - - - - - 12 Ruksha Bhojana + + - - + + +
Page 7
Review of Literature
13 Shalooka + - - - - - - 14 Sheeta Anna Sevana - + - - + + + 15 Sheeta Jala Pana + + + + + + + 16 Sleshmala Aahara + - - - - - - 17 Tila Taila + - - - - - - 18 Vidahi Bhojana + + - - + + + 19 Vistambhi Bhojana + + - - + + +
VIHARA SAMBANDHI
CS SS AS AH BP YR MN 20 Adhvagamana + + - - + + + 21 Adhyashana - + - - - - - 22 Anala - + - - - - - 23 Anila + + + + + + + 24 Atapa - - - - - + + 25 Ati Vyavaya + + - - - - - 26 Ati Vyayama + + - - + + + 27 Dhuma + + + + + + + 28 Karmabhara - + - - + + + 29 Raja + + + + + + + 30 Samashana - + - - - - - 31 Sheeta Jala Snana + - - - + + - 32 Sheeta Sthana Vasa + + - - - - + 33 Vegavidharana - + - - + + + 34 Vishamashana + + - - - - -
NIDANARTHAKAR ROGAS CS SS AS AH BP YR MN 35 Alasaka + - - - - - - 36 Amapradosha + + - - - - - 37 Amatisara - - + + - + - 38 Anaha + - - - - - - 39 Atisara + - - - - - - 40 Chardi + - + + - + - 41 Dosha Prakopa - + + + - + - 42 Dourbalya + - - - - - - 43 Jwara + - + + - + - 44 Kasa - - + + - + - 45 Kshaya + + - - - - - 46 Pandu + - + + - + - 47 Pratishya + - - - - - - 48 Raktapitta + - - - - - - 49 Udavarta + - - - - - - 50 Vibandha + - - - - - - 51 Visuchika + - - - - - -
Page 8
Review of Literature
UPAKRAMA SAMBANDHI
CS SS AS AH BP YR MN 52 Ati Rukshana + - - - - - - 53 Vamana Atiyoga + - - - - - - 54 Virechana atiyoga + - - - - - - 55 Abhighata - + - - - - - 56 Kanthapratighata + - - - - - - 57 Kshatha + - - - - - - 58 Marmaghata + - + + - + - 59 Uropratighata + - - - - - - 60 Visha + - + + - + - 61 Durdina - + - - - - - 62 Meghaachidata
Dina + - - - - - -
The etiologies listed above can independently cause the imbalance of Vata and
Kapha dosha, some factors which may vitiate pitta dosha as well as dearrange the
pittasthana. Most of the factors vitiates the dosha through the Amashaya. Some other
factors like exposure to dust directly provoke the vata dosha in pranavaha srotas.
Concept of Dusivisha can be correlated with the allergic manifestation. The type
of poisonous substances which manifests its poisonous effects after the lapse of some
time is called dusivisha19. This visha vitiates blood and produces symptoms like uru
(eczema), Kitima (Psoriasis) Kothal (Urticaria). It when remains in amashaya produce
kapha vataj disorders 20. Shwasa is told as Amashayottha and Kaphavataj disease
Madhavakara has included shwasa in the list of disorder produced by dushivisha21. Thus
if we consider dushivisha as allergic factor is not incorrect.
Page 9
Review of Literature
SAMPRAPTI
The unique nature of Samprapti of Tamaka shwasa determines this clinical
presentation of illness.
Some nidanas mentioned in classics, for which normal person on exposure rarely
get affected but patients of Tamaka shwasa, suffers from an episode of Tamaka shwasa.
Ayurveda explain this phenomenon as Avyadhisaha sharira (lack of resistance) to
the illness22. To elaborate either because of the faulty habits or due to mal development or
else the result of inborn errors related to the Pranavaha srotas predisposes to illness.
Variations in the environment, rainy season cloudy atmosphere, winter, smoke, dust are
described as enemies of the patient23 having weak Pranavaha srotas.
The intermittent nature of the environmental variation determines the episodic
nature of the Tamaka shwasa 24. As year passes more attack of Tamaka shwasa becoming
more and more frequent and ultimately looses its episodic nature and becomes a
continuous phenomena with excecerbations and remissions.
Charaka has told Tamaka shwasa as “Kaphavatatmakavetou pittasthana
samudbhava” it may be to indicate the two way pathogenesis occurring in Tamaka
shwasa. Most of the factors vitiates the dosha through the amashaya (Pittasthana
samudbhava) these nidanas lead to doshodhirana, agnimandhya, ama, this ama and excess
secreted kapha cause the obstruction in prana vaha srotas (Pranavahasrotomula
mahasrotas) that led to vilomagati of prana vayu
Some factors like exposure to raja dhumu directly provoke the vata dosha in
pranavahasrotas
Page 10
Review of Literature
Chart No. 1
Vata Kapha prakopaka nidana
Doshodhirana Vata kapha prakopa in Pranavaha srotas Sanchay [Sanchayaprakopadi avastha] Agnimandhya Ama
Obstruction of srotas Tamaka shwasa
Prakopa
Doshaprakopa
Prasara
Sthana samsraya Pranavaha srotas
Vyakta Tamaka shwasa
Vata and Kapha both are involved in this disease. Vata dosha is best treated by the
snigdha line of treatment, where as kapha best treated by ruksha line of treatment thus
naturally contradictory thus posing practical problem. Kapha dosha and Rasa dhatu
belong to same categories. It is a general principle of pathogenesis that the dosha and
dusya belonging to the same category rapidly progress in the process of pathogenesis. In
Tamaka, Kapha dosha afflicts the Rasa dhatu.
Independent vitiation of Pranavata and Kapha dosha occurs in Tamaka shwasa
due to the effect of specific etiological factors. By virtue of its Ruksha, Sheet and Khara
qualities the abnormal Prana vayu renders hardening and narrowing of Pranavaha srotas.
The normal upward course of the Prana vayu is obstructed by the abnormally
congested Pranavaha srotas 25.
Page 11
Review of Literature
Sleshma is the normal secretion and is abnormally increased by the vitiated Prana
vayu. Vitiated Prana vayu also irritates the Nasa causing increased secretion and
manifestation like Peenasa, Kshawathu etc.26.
Samprapti has been classified as Sankhya, Pradhanya, Vidhi, Vikalpa, Bala and
Kala according to Acharya Charaka27. By detail study of Hetu, Samprapti, Lakshanas and
Sadhyasadhyata of Tamaka shwasa, it can be elaborated in the frame work of samprapti
bhedas as.
Sankhya:
Tamaka shwasa doesn’t have direct classification to fit in the Sankhya samprapti
have Pratamaka and Santamaka as the avastha bhedas28. Where as Tamaka shwasa is
categorised under Pancha bheda of shwasa.
Pradhanya:
Acharya Charaka has considered Kapha vatamaka vyadhi29. Where as
Madhavakara considered Tamaka shwasa as Kapha Pradhana vyadhi30. Samprapti of
Tamaka shwasa indicates Pradhanyata of Kapha, where as according to the clinical
course of the disease and principles of treatment both kapha and vata seems to be
Pradhana. Vata holds prime importance in the management of Tamaka 31.
Vidhi:
Tamaka shwasa can be classified in different categories under Vidhi samprapti as.
Ashukari32, Yapya33, Krichra sadhya34 Acharya Charaka has considered hikka and
shwasa as Ashukari, Ghora and Sheeghra pranaharaka. TS with chronicity more than one
year are considered as yapya and of duration less than one year in durbala rogi, as
Krichra sadhya Acharya Sushruta has considered TS as Krichra sadhya and asadhya in
durbala rogi.
Page 12
Review of Literature
Vikalpa:
Prana vayu is aggravated by the property such as Sheeta, Ruksha gunas and
increase in its chala guna. Similarly Urasthita Avalambaka kapha gets aggravated by
guru, Snigdha, Sheeta, Abhisyandi and becomes Ghana and Picchila.
Bala
Balabala of vyadhi depends on the virulence of hetus, presence of Porvarupa in
their developed form or in the course of development and also the involvement of
different srotas, rogamargas and involvement of the vital parts of the body. Hence the
bala of the vyadhi differs from individuals. Even though TS can be considered as balavan
and Ghora vyadhi.
Kala:
It is episodic paroxysmal and mostly nocturnal in its nature, Tamaka shwasa is
mostly precipitated or aggravated in the winter and autumn due to cold climate 35 and
concentration of air borne pollens.
Factors involved in the generation of Samprapti of Tamaka shwasa are elaborated
in the following lines.
1. Dosha - Vata, Kapha dosha
2. Dhushya - Rasa Dhatu
3. Srotas - Pranavaha, Udakavaha, Annavaha
4. Srotodusthi - Sanga, Vimargagamana- Atipravarti
5. Utpattisthana - Amashaya
6. Sanchar Sthana - Urakantha
7. Vyaktha sthana - Uras
8. Rogamarga - Abhyantara
9. Adhistana - Pranavaha srota
Page 13
Review of Literature
POORVA RUPA
In classics, Poorva rupa is explained as 36
1) Samanya i.e. which predicts the on coming disease.
2) Vishista i.e. which not only predicts the on coming disease, but especially about
the doshic subtype of the particular on coming disease (Madhukosha).
In case of Tamaka shwasa there is reference of vishista poorva rupas. All Acharyas have
explained regarding Samanya Poora rupas of shwasa.
Table No. 2 Showing the Poorva rupa of shwasa/Tamaka shwasa
POORVA RUPA
Sl.No. CS37 SS38 AS39 AH40 BP41 YR42 MN43
1. Anaha + + + + + + + 2. Adhmana - - - - + + + 3. Arati - + - - - - - 4. Bhaktadwesha - + - - - - - 5. Hritpeeda + + + + + + + 6. Kantha gurutwa + - - - - - - 7. Kashaya
vadanata + - - - - - -
8. Parswa shoola + + + + + + + 9. Prana vilomata + - + + - - - 10. Shankha Toda - - + + + + + 11. Uro guruta + - - + - - - 12. Vaktra vairasya - + - - + + +
Premonitory symptoms explained by A.F Golwall or sneezing, flatulence,
drowsiness or restlessness, irritability dry irritant cough may precede or accompany
attacks of wheezy breathlessness and called it as asthmatic aura. Polyuria and itching are
added to above in the text of Suraj Gupta. At the onset of an attack patients experience a
sense of constriction in the chest with an unproductive cough (ER Mc Fadden).
Page 14
Review of Literature
RUPA
Predominant factors involved in pathogenesis of Tamaka shwasa are vata and
kapha dosha, rasadhatu and pranavaha srotas. The classics have explained the lakshanas
of Tamaka shwasa in continuous flow which represents the clinical course of disease. The
Vyakta lakshanas can be classified as Samanya lakshanas, Vishista/Pratyatma lakshanas
and Upashanupashaya rupi lakshanas.
Samanya lakshanas start with shirogreeva to the ‘meghambuseetapragvatahi
sleshmalaschiva abhivardhe yate’.
Some of the symptoms can be considered as Vishista/Pratyatna lakshanas are:
Swaskrichrata, Kasa Ghurghurata (added sounds), Pramoha. Other symptoms indicates
the upashaya anupashaya swaroopi lakshanas.
Table No.3 Lakshanas of Tamaka
LAKSHANAS
No CS44 SS45 AS46 AH47 BP48 YR49 MN50
1 Ghurghuraka + + + + + + + 2 Shayanasya Shwasapeedita + + + + + + + 3 Peenasa + - + + + + + 4 Lalata Sweda + + + + + + + 5 Meghaambusheetapragvatair
Vardheyat + + + + + + +
6 Ateeva Teevra Vega Shwasa + - + + + + + 7 Prana Prapeedana + - + + + + + 8 Pratamyati + - + + + + + 9 Muhur Muhur Pramoha + - + + + + + 10 Sleshma Vimokshante Kshanam
Sukham + - + + + + +
11 Muhusvaso Muhuschiradhmayate + - + + + + +
12 Aseenolabhate Sukham + - + + + + + 13 Ushnabhinandana + - + + + + + 14 Uchritaksha + - + + + + + 15 Kasa + + + + - - - 16 Sannirudha + - - - + + + 17 Sleshmanya Amuchyamane
Dukhitaha + - - - + + +
18 Vishuskasya + - + + + + +
Page 15
Review of Literature
19 Aruchi - - + + - - - 20 Parshva Shula - - + + - - - 21 Trishna - + + + - - - 22 Shayanasya Parshva Graha + - - - + + + 23 Nidram na Labhante + - - - + + + 24 Krichra Bhashana + - - - + + + 25 Kanthodhwamsa + - - - + + + 26 Vepatu - - + + - - - 27 Trasyate - - - - - + - 28 Kapha Heene Shamayate - + - - - - - 29 Annadvit - + - - - - - 30 Vamathu - + - - - - -
It is easy if one categorises the clinical features into subjective and objective
features.
1) Subjective features (symptoms) Ex: Parswa peeda, Aruchi, Trishna, Pramoha,
Shirogreeva sangraha etc.
2) Objective features (signs) Ex: Teevra shwasa roga, Gurguraka, Shabda, Kasa,
Peenasa, Uchritaksha.
In addition as for as Tamaka shwasa is concerned there are two more stages have
been mentioned and their features are stated. Due to the Udavarta, Raja, Ajeerna, Klinna
ahara and Vegadharana, Pratamaka shwasa is caused, having features like Jwara,
Moorcha in addition to the Tamaka shwasa lakshanas 51.
Santamaka shwasa on the other hand is caused due to the tamovardhana and
makes the patient to go deep into darkness more over it subsides by seetopachara 52.
Shwasa:
Teevra vega shwasa is produced due to the aggravated vata and due to its
pratilomagati led by Kaphavarodha. Patient is likely to experience Hridaya peedana 53.
Expiration becomes difficult due to obstruction. Forceful respiration results, its audibility
with a wheeze.
Page 16
Review of Literature
Kasa:
It is produced as a result of Kapha aggravation, which produces obstruction Kasa
is effort to clear this obstruction, at the onset of attack. Since Kapha does not come out,
the patient becomes all the more restless. He is relieved for sometime soon after the
kapha comes out54.
Muhur Muhur shwasa:
In extreme situations, Ghurguraka may lessen, even disappear cough may become
extremely ineffective and patient may suffer from a gasping type of respiratory effort
because of excessive mucous plugging and impending suffocation. This phenomena have
been mentioned as feature Muhur Muhur shwasa 55, Pranaprapeedana can be attributed.
Aseeno labhate sukhamsayane56
shwasa peedana is seen implying the influence of posture. The sticky and liquid
Kapha (mucous) spreads all over the bronchial passage in supine position. Causing the
severe obstruction to the major bronchiole leading to severe distress in the patient. But
when the patient acquires a erect position, the major bronchioles are cleared for
respiration as mucous settles down only in the alveolar level. The respiratory muscles are
little comfort in Aseena than Shayana and also position of diaphragm influences the
respiration.
Usna Chivabhinandati57
The patient develops special liking for hot things against the sheetala guna of
kapha, which probably results in to Kapha vilayana, thus srotomukha vishodhana.
Page 17
Review of Literature
UPASHAYA – ANUPASHAYA
Upashaya
“Oushadhadi janita Sukhanubandha upashaya”58
Any of the Dravyabhuta (Oushadhi, Ahara) or Adaravyabhuta (Vihara) Upacharas
which leads for Sukhanubandha is Upashaya.
Sleshma Vimokshana, which can be achieved by mechanical process such as
coughing59, by pharmacological measures such as administrating sleshmavilayana
dravyas. The dravyas possessing Ushna properties can be administered as Upashaya 60.
Non pharmacological procedures such as change of position, changing to the sitting
position from recumbent position, relieves from the severity for short period 61. Kala
other than Meghakala, Durdina can be considered as Upashaya.
Anupashaya
“Veparito anupashayo vyadhyasatmyam iti smrita” 62
Aupashaya is considered contradictory to Upashaya i.e. factors such as Ahara,
Vihara and Oushadhi, which aggravates the condition of disease called Anupashaya.
Meghambusheetapragvatai sleshlamalaischabhivardhayate is called as
Anupashaya63.
“Shayanasha shwasapeedithaha” indicates the aggravation of the disease in the
recumbent position 64.
Page 18
Review of Literature
UPADRAVA ARISTHA & SADHYASADHYATA
Upadrava
There is no any direct reference regarding the Upadravas of Tamak shwasa. In the
context of Trishna chikitsa, Charaka chikitsa sthana 22/7 has explained, manifestation of
Trishna as Upadrava. Dalhana states that Deerga kalanubandhi lakshanas of a disease can
be called as Upadrava.
Aristha
Regarding the Aristha laxana, there is no direct reference in the context of
Tamaka shwasa, where as in reference with different contexts aristha lakshanas for
shwasa can be established. It is mentioned that the person producing unnatural sounds
with heavy respiration, suffering with Atisara, Trishna, Shushkasyata and loss of body
strength is definitely going to die 65.
The person whose Urdhva shwasa is rapid, throat occluded by Kapha, reduction in
strength, complexion and food intake is not going to survive for longer period 66. The
person of shwasa presenting with feeble and shallow respiration, feels of tearing pain all
over the body is mentioned of having short life span 67. The person taking long
inspiration and gives of short expiration gets fainted, such person is stated to die within
short period 68.
Sadhyasadhyata
Tamaka shwasa with chronicity more than one year are considered as Yapya and
of duration less than one year in the durbala rogi, as Krichra sadhya 69. Acharya Sushruta
has considered T.S as Krichrasadhya and asadhya in durbala rogi 70. According to
Vaghbhata Tamaka shwasa is sadhya before it is manifested completely (Aspasta avasta)
and become prananasaka when gets manifested completely71.
Page 19
Review of Literature
VYAYACHEDAKA NIDANA
Table No. 4 Showing differential diagnosis of shwasa
Laxana Tamaka
Shwasa
Maha
Shwasa
Urdhva
Shwasa
Chinna
Shwasa
Kshudra
Shwasa
Shwasa Atteva teevra
vega shwasa
Uchaihi
shwasati
Dheergam
shwasati,
Urdhvam
shwasati,
adhoshwasa
nirodha
Shwasate
vichinnam
Ruksha
ayasottha
shwasa
Shabdha Ghur-ghuraka
Matta
vrashabho
vatt
---- --- ---
Consciousness Pramoha
Pranastha
jnana
vijnana
Pramoha Moorcha ---
Netra Uchritaksha
Vibhranta
lochana
and
vivrataksha
Urdhvadristhi
and
vibhrantaksha
Viplutaksha,
raktaika
lochana
---
Shula Shayanasya
parshvagraha --- Vedanarta
Marmachedavat
rugarditaha ---
Vak Kruchrakrichnoti
bhashitaha
Viksheena
vak --- Pralapana ---
Asya Vishushkasya --- Shushkasya Parishushkasya ---
Sweda Lalata sweda --- --- Sarva daihika
sweda ---
Upashaya Sleshma
vimokshana --- --- --- ---
Sadhyasadhyata Yapya Asadhya Asadhya Asadhya Sadhya
Page 20
Review of Literature
CHIKITSA VIVECHANA
Tamaka shwasa, in its pathology involves multiple varying factors, vitiated Vata,
Kapha afflicting the Rasa dhatu from their root in pittasthana manifesting in Pranavaha
srotas. Therapies for the treatment of the patient suffering from shwasa can be divided in
three 72
1. Therapy which alleviates both Kapha and Vayu.
2. Therapy which alleviates Kapha but aggravates Vayu.
3. Therapy which alleviates Vayu but aggravates Kapha.
Among three first type should always be preferred out of the remaining two
categories, the last one can, however be administered if found essential, in exceptional
circumstances. The second category of therapy should be avoided. The therapy which
alleviates Vayu is generally nourishing (bramhana). Administration of such therapy may
produce some adverse effects, but such adverse effects would be minimal and not
difficult to cure because the patient will gain strength by nourishing therapy as a result of
which he can easily overcome these adverse effects.
The depletion therapy (Karshana) on the other hand would create tremendous
amount of adverse effects, which may be incurable. It is only the alleviation therapy
which is absolutely free from these adverse effects & such a therapy should be preferred
for the treatment of shwasa 73.
Fundamentals of management of Tamaka shwasa have been explained exclusively
by Acharya Charaka. The principles of management are.
Nidana parivarjana:
One has to be very precise regarding the precipitating or triggering factors, avoid
exposing to that particular factor, which mostly helps to prevent the onset of acute
episodes. It is also justified by Acharya Sushruta statement ‘Sankshepatha Kriyaprokta
nidana parivarjanam’74. Tamaka shwasa is a heterogenic disease, have a wide range of
etiological factors, it becomes difficult to identify the specific cause and avoid it.
Page 21
Review of Literature
More ever it is a typical disease where in the initial sensitization by specific factor
sets a platform for the onset of acute episodes with exposure to even smallest or mildest
stimuli hence it becomes difficult to manage the condition, only by nidan parivarjan. So
as to control the condition the systematic management procedures are explained they are,
Snehana and Swedana
Bahya snehana on uras by lavana taila, as an intial course of action swedana
followed by either of (Nadi, prastara or Sankara). Swedan measures with the help of
snigda dravyas, helps for liquification of the grathita kapha, facilitating easy expelling of
vitiated kapha helps for Vatanulomana, smoothness of srotas. Swedana is contraindicated
in pitta dosha predominant, person of pittaj prakrati, persons suffering from daha,
raktapitta, atisara, dhatu ksheenata, bala ksheenata, gharbini, person of Ruksha prakrati.
In them mridu swedana has to be performed i.e. parisheka by ushna snehas,
sharkarayukta ushna utkarika or upanaha 75.
Vamana
Vamana is not ideal choice for the patients present with symptoms suggestive of
dominant vata dosha. In patients with the predominant vitiation of Kapha dosha, Vamana
karma is most ideal who present with symptoms like paroxysmal productive cough where
sputum is tenacious, bouts of distressing paroxysmal cough brings small amount of sticky
sputum.
Vamana is advisable only in patients who are physically strong and can tolerate
the strain of Vamana karma 76. After Abhyanga and Nadi sweda over the chest, in the
evening the food that provokes the Kapha; like meals with curds or fish is given to
patient, which helps in the easy elimination of Kapha dosha by Vamana procedures.
Dhoomapana:
It is advised after Vamana karma and it eliminates Kapha dosha still left out after
Vamana karma 77. In patients who are debilitated where purificatory procedure is not
possible in them dhoomapana alone can be given which helps for the elimination of
Kapha dosha. It also brings relief by reducing spasm or stiffness of Pranavaha srotas, thus
ensures free movement for Vata dosha.
Page 22
Review of Literature
Virechana:
Management of swas rogi depends on
1) Bala bala (Balawan or Durbala)
2) Doshadhikya (Kapha or Vata)
In case of Kpahadhikya, balawan rogi, doshas are to be expelled by Vamana and
Virechana, maintaining Pathya ahara, Vihara and later followed by
Shwasanashakandhuma, avaleha etc. In case of Vatadhikya, Durbala, Vruddha,
Vatanashak dravyas, tarpana, sneha, yusha, Mamsarasa etc should be used 78. If
Samshodhana is performed in condition of anutklistha Kapha, durbala, who have not
undergone swedana, vata gets grossly provoked becomes fatal causing
marmasamshoshana 79.
Obstruction in Pranavaha srotas because of sticky kapha is best relieved by
Vamana. Where as doshas stemming out from pitta sthana is best eliminated by
Virechana procedure. Virechana normalizes the course of vata dosha and thus helps in the
reversal of the vilomagati of pranavayu 80. Distension of abdomen, constipation and such
other symptoms may be associated in some patients and these symptoms are best treated
by this procedure.
Doshanubandhi Shwasa chikitsa:
In case of Vatanubandhi shwasa, the ghrita prepared by mamsa of shosha,
shallaka etc. and ghrita prepared by pippali, mamsa and shonita has to be administered 81.
In case of Vatapittanubandhi shali odana prepared with Souvarchala, dugdha, ghrita and
trikatu has to be administered 82. In case of Kaphapittanubandha, Shirisha pushpa Swaras
or Saptaparna swaras mixed with pippali choorna and madhu has to be administered 83.
If the path of pranavayu is obstructed by Kapha Ksharavaleha has to be
administered in order to relieve the obstruction of pranavayu 84.
Intelligent physician has to expel doshas by Vamana if patient is suffering from
Kasa, Swarabhanga, and by Virechana by Kaphavatahara dravyas in Tamaka85
Page 23
Review of Literature
Gangadhara comments on it states to administer Kaphavatahara virechana in
swarabhanga yukta shwasa and Tamaka shwasa.
Nasya prayoga:
Different yogas such as rasona, palander, grinjanaka swarasa, madhura varga
dravyas siddha ghrita are indicated for nasya karma for hikka in the context of hikk and
shwasa chikitsa, but it is not directly indicated in shwasa, Vagbhata also supports the
same, where as Arunadatta commenting on the same indicates nasya prayoga in shwasa
also.
Acharya Sushruta explains the utility of Bhringaraja siddha taila as nasya,
ahyanga and acchapana 86. Shwasa rogi having ruksha shareera suffering from shuskata
in uros kanta and talu has to be treated by ghrita 87.
Management of Shwasa according to Doshas
Acharya Charaka explains a special modality of treatment in managing the
shwasa rogi with respect to doshas. Vatakruddha kaphahara: i.e. the upakramas which
aggravates vata and mitigates kapha. Kaphakruddha Anilopham: the upakramas which
aggravates kapha and mitigates vata.
Treatment aiming towards single dosha must not be performed i.e. Vatakaraka,
Kaphakaraka, Vatashamaka or Kaphashamaka. In indispensable condition to implement
one amongst the above four, it is mostly superior to go for vatashamaka upakramas 88.
Brimhana and Rasayana chikitsa:
Atmospheric changes which rarely have any effect in normal person reflects as
disease in patients is due to Khavaigunya, an abnormality of the Pranavaha srotas. This
can be rectified by Vyadhihara rasayana. This unique treatment may be much helpful in
subsiding the attack of Asthma. Also in due course, improves the resistance power by
Pranavaha srotas, chronic illness emaciate the body, in the Brimhana chikitsa is going to
help 89. With all above principles of management of Tamaka there are many number of
swasha yogas explained in the context of hikkashwasa chikitsa.
Page 24
Review of Literature
PATHYA APATHYA
Knowledge of Pathya, Apathya is very important in preventing the disease. Vata
and Kapha dosha are responsible for the manifestation of disease Tamaka shwasa. Pathya
are those one which pacify the vata and kapha, Apathya are the one which aggravates the
kapha and vata dosha.
Acharya Sushruta and his commentators and Yogaratnakar have explained the
Pathyapathya in separate headings, where as most of the apathyas explained by them are
found in the nidanas of shwasa listed by Acharya Charaka.
Table No.5 Pathya in Tamaka shwasa
AHARA Purana shastika shali84 Purana tandula Kulattha Godhuma Yava Shasaha mamsa Titira mamsa Dakshamamsa Shuka mamsa Dwija (andaja) mamsa Purana sarpi Aja dugdha Aja ghrita Sura85 Madhu87 Patola Vartaka Rasona Bimbi Jambeera Tanduliyaka Vastuka86 Draksha Ela pushkara Ushna jala Nidigdhika Pippali Purana sarpi Jangala mamsa Souvarika Hingu Matulunga Amalaka Bilwa Jeevanti mula Kapotika Katutraya Gomutra88 Kaphavatahara annapana
VIHARA Diwaswapna
UPAKRAMA Virechana Swedana Dhumapana Vamana Agni karma by pradipta loha at vaksha pradesha, yougma parshva, kara madhya, kara urdhva and kantha kupa.
Page 25
Review of Literature
Table No.6 Apathya in Tamaka shwasa
AHARA Mesha dugdha Mesha ghrita Dushita jala Matsya Kanda Sarshapa Ruksha bhojana Sheeta bhojana Guru bhojana Vistambhi Vidahi Anoopa mamsa Taila bhrista nishpava Sleshmala
ahara Masha
VIHARA Poorva vata Gramya
dharma Shrama Adhvabhara
Vega dharana of Mutra, Udgara, Chardi, Trishna and Kasa. Raktasrava
Strictly following the Pathya, Apathya in asymptomatic phase prevent an episode
of disease, which can modify the strength of the disease.
Page 26
Review of Literature
CONCEPT OF VIRECHANA
Virechana karma is one of the important karmas used for the elimination of
vitiated doshas from the body, through adhomarga i.e. from anus 95. The word Virechana
Na, Vi+Rich, Plut – Maladeha Nissaranam. Thus it means to expel doshas/malas from the
body. The term virechana is widely used in a sense of expulsion of secretary or excretory
matter0 from the body.
Ex: Mutra virechana, Sirovirechana, Shkra virechana.
In any case when the term virechan is mentioned alone, it indicates the
elimination of doshas through the anus. Virechana is regarded as the main shodhana
chikitsa for pitta vikaras 96, because the virechana oushadha act mainly in pittha sthana.
For vata rogas also virechana indicated as one of the treatment 97. virechana is told to be
suitable or indicative to the following conditions 98.
1) In diseases where pittha is predominantly vitiated.
2) In diseases where kapha is combined with pittha.
3) In cases where kapha is migrated in huge quantity to pitta sthana.
A seasonal cleansing therapy in healthy person is also recommended for
maintenance of health. Virechana karma is mentioned in Ayurveda not only cures
diseases but also make the body healthy vigorous by expelling the doshas and making the
body soft and increasing the jataragni.
Classification of Virechaka Dravyas: -
Virechana drugs can be classified on the basis of:
1) The intensity of action.
2) The character of action (Gunanusara)
3) The mechanism of action on the intestines.
According to the intensity of action virechana drugs are classified into Mridu,
Madhya, Teekshna Charaka has mentioned, the following drugs as the best for specific
purposes 99.
Page 27
Review of Literature
Sukha virechana - Trivrit
Mridu virechana - Aragwadha
Teekshna virechana - Snuhi ksheera.
According to guna, 1) Snigdha virechana 2) Ruksha virechana.
Snigdha virechana is prohibited to subjects who shows more snehana or who
himself has the athisnigdha symptoms. In this condition Ruksha virechana is indicated100.
According to mechanism of action of the drug on the intestines Sarangadhara has
classified virechana drugs into four categories 101.
1) Anulomana
The virechana dravyas which digests the undigested mala, breakdown the adhesion
and relieves vibandha are called as Anulomaka dravyas.
2) Sramasana
The one which breaks the adhesions irrespective of the pakwa or apakwata of mala
and leads for adhobhaghaharana are called as Sramsana dravyas.
3) Bhedana
The one which breaks adhesions accumulation and hard stools and expels are called
as Bhedaka dravyas.
4) Rechana:
The one which liquifies the mala irrespective of pakwa-apakwa avastha of mala and
expels are called as Rechaka dravyas.
Virechaka dravyas: -
According to different Acharyas, there are number of virechaka dravyas, some of
the non virechaka dravyas are mentioned here under different headings.
Mulini dravyas : Trivruta, Hastidanti, Gavakshi, Saptala etc102.
Phalini : Abhaya, Aragwadha, Kampillaka etc103.
Ksheerini : Snuhi, Arka etc.104
Twak : Tilvaka etc.105
Page 28
Review of Literature
Taila : Eranda etc. 106
Swarasa : Karavellaka 107
Lavana : Saindhava, Souvarchala etc. 108
Acharya Charaka has devoted six chapters in the Kalpasthana only for the sake of
virechana dravyas and their utility. Where as Acharya Sushruta and Vagbhata have
explained elaborately, virechaka dravyas in their Surasthana 44th & 15th chapters
respectively.
Yogya and Ayogya for Virechana:
In all the major classics of Ayurveda, every one has explained virechana yogya
and ayogya as virechya and avirechya. The one among those who are classified under
avirechya are strictly prohibited from undergoing virechana karma. Where as in the
context of virechya and conditions other than avirechya, which are not clearely
mentioned as virechya, depending on the need of the time virechana can be administered.
The reference regarding them is available in Charaka Siddhisthana 2nd chapter, Sushruta
chikitsasthana 33rd chapter and Astanga Hridaya Sutrasthana 18th chapter.
Virechana karma procedure:
For the purpose of satisfactory fulfillment of virechana karma, the procedure is
divided into three phases;
Purva karma:
The activities that are to be performed before administering of virechana dravya,
they are
Sambhara Sangraha – Collection of materials required
Atura pareeksha – The patient has to be thoroughly examined for the Dosha, Bheshyaja,
Desha, Kala, Shareera, Ahara, Satmya, Satwa, Prakruti and Vaya 109.
Atura Siddata – The person who is undertaking virechana has to be subjected by proper
oleation and sudation and later administered virechanopaga bhojana.
Page 29
Review of Literature
Matra vinischaya – The matra of any dravya generally depends on vayu, agni and kostha,
where as in case of virechana, prime importance is given in considering the koshta. The
matra is classified Uttama, Madhyama and Heena 110 and is as following,
Kwatha:
Uttama matra 2 Pala (8 Tola)
Madhyama matra 1 Pala (4 Tola)
Heena matra 0.5 Pala (2 Tola)
Choorna/Kalka:
Uttama matra 4 Pala
Madhyama matra 2Pala
Heena matra 1 Pala
Pradhana karma
It is the main procedure which includes administration of virechaka dravya, vega
Nirekshana and Vyapat nirharana.
Virechana dravya prayoga:
In the early morning, next to the day of Snehana & Swedana, Virechaka dravya is
administered in appropriate dose on an empty stomach.
Vega nireekshana:
After administration of virechaka dravya patient develops vegas after some time.
The first few vegas containing mala are to be excluded and observed for the
corresponding vegas for pitta, Aushadha and Kapha respectively 111.
Observation for Shuddhi Lakshanas:
When the virechaka dravya is administered, one has to observe for the type of
shuddhi i.e. Samyak shuddhi or asamyak shuddhi, asamyak shuddhi may be atiyoga,
ayoga or mithya yoga.
Page 30
Review of Literature
Samyak shuddhi:
Samyak shuddhi lakshanas are considered when the doshas are expelled in order
of mala, pitta, Aushadha and kapha i.e. Kaphantya virechana112 which is objective. It is
also called as antiki shuddhi laxana. Where as in case of laingiki shuddhi
srotovishoddhata indriya prasannata, laghuta, agnideepti and relief from the symptoms of
the disorder are observed113 this type of shuddhi is subjective.
Suddhi prakara:
Based on the number of vegas and quantity of expelled doshas, the shuddhi is
classified as:
Pravara - 30 vegas – 4 prastha
Madhyama - 20 vegas – 3 prastha
Heena - 10 vegas – 1 prastha
Management of Ayoga and Vyapat:
In case if any ayoga lakshanas are observed, immediate action has to be towards
relieving the ayoga lakshanas and facilitating Samyak virechana.
Charakacharya in Siddhistana 6th chapter has elaborately explained regarding 10
types of vamana and virechana vyapat and their appropriate management.
Paschat karma:
The procedure adopted after complete attainment of Shuddhi lakshanas, till the
person attains the normal state of health is called as Paschat karma and is comprised of,
Sansarjana karma, Shamana Chikitsa and Pariharya visheyas.
Sansarjana karma:
The mandata of Agni, due to the Shodhana has to be brought to normal by gradual
process 114, for which a well organized dietic regime was formulated and that regime is
called as Sansarjana karma.
Page 31
Review of Literature
Peya, Vilepi, Akrita-krita yousha and mamsa rasa have to be used in three, or one
annakalas respectively in case of pravara madhyama and avara shuddhi 115. Detail
description regarding Sansarjana karma is available in Charaka Samhita 116.
Table No. 7 showing the Sansarjana karma
Day Annakala Pravarashuddhi Madhyama
shuddhi
Heena suddhi
1 Morning --- --- --- 1
2 Evening Peya Peya Peya
3 Morning Peya Peya Vilepi 2
4 Evening Peya Vilepi Krita yusha
5 Morning Vilepi Vilepi Krita mamsarasa 3
6 Evening Vilepi Akrtia yusha Prakrita bhojana
7 Morning Vilepi Krita yusha 4
8 Evening Akrita yusha Akrita mamsarasa
9 Morning Krita yusha Krita mamsarasa 5
10 Evening Krita yusha Prakrita bhojana
11 Morning Akrita mamsarasa 6
12 Evening Krita mamsarasa
13 Morning Krita mamsarasa 7
14 Evening Prakrita bhojana
Shamana chikitsa:
After Sansarjana karma in order to pacify the residual doshas if any, Shamana
aushadhis are administered.
Pariharya visheys:
In order to get the maximum benefit and to avoid ill effects of Samshodhana
Acharyas have advised to strictly avoid certain activities and such restrictions are called
Pariharya visheyas.
Page 32
Review of Literature
MODERN REVIEW
Anatomy:
The respiratory system is divided for descriptive purposes in to the upper and
lower respiratory tracts. The dividing line being the lower border of cricoid cartilage.
The upper respiratory tract:
The upper respiratory, which includes the nose, nasopharynx and the larynx, is
lined by vascular mucous membrane covered by ciliated columnar epithelium. The rich
blood supply ensures that the inspired air enters the lungs at body temp and fully
saturated with water vapour. The cilia aided by the layer of sticky mucous covering them,
have the important function of trapping foreign particles and bacteria and propelling them
towards the pharynx. The nasal sinuses communicate with the nasal cavities by narrow
openings and frequently involved in nasal and nasopharyngeal infections.
The larynx in addition to being the organ of voice production has the function of
preventing the particles larger than can be dealt with by the cilia from reaching the lower
respiratory tract. This it does by means of cough reflex. As the left recurrent laryngeal
nerve runs part of its course within the thoracic cavity in close relation to the aortic arch
and the left pulmonary hilum a bronchial carcinoma in the left hilar region and less
frequently an aortic aneurysm may cause paralysis the left vocal cord.
The Trachea, Bronchi and Lungs:
The Trachea begins at the cricoid cartilage and ends at the level of the sternal
angle by bifurcation into two main bronchi. The trachea is usually palpable in the
suprasternal notch. The right principal bronchus is shorter (1inch) wider, the left principal
bronchus is longer (2 inches) narrower and more oblique than the right bronchus.
Each principal bronchus enters the lung through the hilum, and divides into
secondary (lobar) bronchi one for each lobe of the lungs (3 on the right side and 2 on left
side). Each lobar bronchus divides into tertiary (segmental). One for each
Page 33
Review of Literature
bronchopulmonary segment (10 on the right side and 8 on the left side). The segmental
bronchi divide repeatedly to form very small branches called terminal bronchioles. Still
smaller branches are called respiratory bronchioles.
Each respiratory bronchiole aerates a small part of the lung known as pulmonary
unit. The respiratory bronchiole ends in microscopic passages which are termed (in that
order) as i) alveolar duess, ii) atria, iii) air succules, iv) pulmonary alveoli gaseous
exchange take place in the alveoli.
Pleura:
Each lung is closely invested with visceral pleura parietal pleura lines the chest
wall, mediastmum and diaphragm and is continuous with the visceral pleura at the lung
hilum. In health the two pleural layers are separated only by a thin film of lymph, but
between them there is a negative tension.
Mediastinum:
The anatomy of the mediastmum has an important bearing on the diagnosis of
intra thoracic disease, particularly tumours and aneurysms. These lesions are liable to
involve mediastinal structures and as a result readily recognizable symptoms, physical
signs and radiological abnormalities may be produced.
Physiology:
Ventilation & Exchange of gases in the lungs:
The pulmonary ventilation-rate (minute-volume) is normally about 6 lts/ minute at
rest and may reach 100 lts/minute during the heaviest exercise. It is controlled by the
respiratory center in the brainstem (medulla oblongata and phenotoxic center in the
pansvaroly) the activity of which is influenced by many factors.
The most important of these are cortical activity (breathing may be altered voluntarily)
CO2 excess metabolic acidosis, lack of oxygen, body temperature and impulses from
pulmonary stretch receptors and possibly from receptors in the limbs Hyper ventilation
due to excess CO2 is thought to be due to increase in hydrogen-ion concentration within
Page 34
Review of Literature
or around cells of the respiratory center and metabolic acidosis acts in the same way. The
center is stimulated reflexly, via the carotid bodies by a fall in the partial pressure of
oxygen (PO2) in the arterial blood. The control by CO2 and hydrogen ions is more
important for the day today regulation of breathing, but the effect of a reduced PO2
(hypoxia) is less affected by drugs or by deep unconsciousness and is thus important for
survival. Apart from its own stimulant effect, hypoxia increases the sensitivity of the
respiratory ‘Centre’ to CO2 in healthy subjects. Contrary to widespread belief there is no
direct evidence that acute or chronic hypoxia is ever responsible for lowering
responsiveness to CO2 in disease though severe hypercapnia (rise in PCO2) does depress
both CO2 response and consciousness.
About one quarter of minute-volume ventilates the conducting airway
(respiratory dead-space) the remaining three quarters constitutes the alveolar ventilation.
Ventilation of the dead space increases with respiratory frequency. When frequency is
high, therefore a greater total ventilation is needed to yields a normal alveolar ventilation.
Hypoventilation of the alveoli may occur, when the respiratory center is depressed by
narcotics anaesthetics or intra cranial disease or when there is paralysis affecting.
Normal alveolar ventilations are not fully effective unless it is distribution
uniformly to different parts of the lungs and is matched by uniform description of
pulmonary arterial blood. When there is considerable mismatching, incompletely
oxygenated blood leaves alveoli, which are under ventilated or over perfused. Although
this blood mixed in the left atrium with fully oxygenated blood from well-ventilated
alveoli some degree of hypoxia is inevitable. At first arterial PCO2 may remain normal as
a result of compensatory hyperventilation of some alveoli, but with gross defects of
distribution, there is hypercapnia as well. Breathing oxygen corrects the hypoxia unless
considerable amount of lung is completely unventilated but not relieve hypercapnia.
Abnormalities of distribution are very common and occur especially in emphysema,
asthma and organic bronchial obstruction.
Page 35
Review of Literature
Asthma:
Asthma is characterized by episodic reversible bronchospasm resulting from an
exaggerated broncho constrictor response to the various stimuli.
The basis of bronchial hyper reactivity is not entirely clear, but it is widely believed to
result from persistent bronchial inflammation. Hence bronchial asthma is best considered
a chronic inflammatory disorder of the airway, clinically, asthma is manifested by
episodic dyspnoea, cough and wheezing. This common disease affects about 5% of adults
and 7-10% of children. It can be classify in to 2 category.
1. Extrinsic Asthma:- In which asthmatic episode is typically initiated by type I
hypersensivity reaction induced by exposure to an extrinsic antigen. Three types of
extrinsic asthma are –Atopic asthma, Occupational asthma and Allergic bronco
pulmonary aspergillosis. Atopic asthma is the most common type of asthma, it’s on
set is usually in the first two decades of life associated with other allergic
manifestations. Serum IgE levels are usually elevated, as is the blood eosinophil
count.
2. Intrinsic Asthma:- In which the triggering mechanisms are nonimmune. In this form,
a number of stimuli that have little or no effect in normal subjects can trigger
bronchospasm. Such factors include Aspirin, pulmonary infections; especially those
caused by viruses cold, psychological stress, exercise and inhaled such as sulfur
dioxide.In many cases a neat distinction between intrinsic and extrinsic asthma is not
possible.
Pathogenesis:
Exaggerated bronchoconstricar response to a variety of stimuli is common to all
forms of asthma. Although the importance of increased airway reactivity is
established, the basis of the abnormal bronchial response is not fully understood.
Most current evidence suggest that bronchiole inflammation is the substrate for
hyperresponsiveness, persistence inflammation of the bronchi manifested by presence
Page 36
Review of Literature
of inflammatory cells and by damage to the bronchial epithelium, is the constant
feature of bronchial asthma.
Atopic Asthma:-
Like all type I hypersensitive reactions, allergic asthma is driven by sensatisation
of CD4+ cells of the TH
2 type. It may be recalled that TH2 cells release cytokines such
as intelucin 4 &5 (IL-4 &IL-5) that favour the synthesis of IgE growth of mast cells
(IL-4) & growth and activation of eosinophils (IL-5) IgE, mast cells & eosinophils
are key players in the allergic asthma.
Attacks of atopic asthma often demonstrate in two phases. An early phase, beginning
30-60 minutes after inhalation of antigen and then remitting, followed 4-8 hours later
by a more protracted late phase. As might be expected the initial triggering of mast
cells occurs on the mucosal surface, the resultant mediator release opens mucasal
intercellular junction allowing penetration of the antigen to more numerous mucosal
cells. In addition direct stimulation of subepithelial vagal receptors provokes reflex
bronco constriction. Mast cell activation lead to the release of a variety of primary
and secondary mediators. Leukotrienes C4 D4 & E4, Prostaglandin D2 (PGD2),
Eosnophilic & neutrophilic chemo tactic factors & leakotriene B4, Platelet-activating
factor (PAF) which causes aggravation of platelets & release of histamine from their
granules.
Together these mediators induce broncho constriction, oedema & mucus
secretion. These are followed by the late phase in which leukocytes are dominant,
basophiles, cytokines such as tumour necrosis factor α from mast cells that up
regulate adhesion molecules on vascular endothelium & also on inflammatory cells.
Not only these release the mediators & thus intensify the initial response. They also
cause epithelial cell damage. epithelial cells themselves are source of mediators, such
as endothelium & nitric oxide (NO) that can cause smooth muscle contraction &
relaxation respectively. Loss of epithelial integrity by reducing available NO, may
Page 37
Review of Literature
thus contribute to airway hyper responsiveness. eosinophils are particularly important
in the late phase. Their accumulation at sites of allergic inflammation is favoured by
mast cells derived chemo tactic factory IL-5 & Paf. Recent studies have implicated
several chemokines in eosinophil chemotaxis. The most potent of these appears to be
eotoxin, produced in part by activated bronchial epithelial cells. The accumulated
eosinophils exert a variety of effects. Eosinophils can amplify & sustain the
inflammatory response without additional exposure to the triggering antigen.
Intrinsic asthma:
The mechanism of bronchial information & hyper responsiveness is much less
clear in patients with intrinsic asthma & incriminated in such case are viral infection of
the respiratory tract & inhaled air pollutants such as sulfur dioxide ozone & nitrogen
dioxide. These increases hyperactivity in both normal and asthmatic. In the latter
however, the bronchial response is manifested as spasm is much more severe &
sustained.
Clinical course:
An attack of asthma is characterized by severe dyspnoea wheezing. The chief
difficulty lies in expiration the victim labours to get air into the lungs and then cannot get
it out, so that there is progressive hyperinflation of the lungs with air trapped distal to the
bronchi, which are constricted and filled with mucus and debris. In the usual case, attacks
last from 1 to several hours and subside either spontaneously with therapy, usually
bronchodilations corticosteroids. Intervals between attacks are characteristically free
from respiratory difficulty but persistent subtle respiratory deficits can be detected by
spirometric methods. Occasionally a severe paroxysm occurs that does not respond to
therapy and persists for days and even weeks, associated hypercapnia, acidosis and severe
hypoxia may be fatal although in most cases the disease is more disabling than lethal.
Page 38
Review of Literature
Page 39
DRUG REVIEW
Vata and Kapha are the doshas involved in the Samprapti of the Tamaka Shwasa.
Thus medicine alleviates both vata and kapha should be selected according to
Charakacharya has advised to select the drugs having vata kaphahara properties for the
virechana. 117.
In this study, Shunti phanta consisting shunti which does the agnideepana is used
for, agnideepana and amapachanartha.
Tila taila in which Saindhava is mixed is used for bahyabhyanga at ura pradesha.
Tila taila has qualities like ushna, teekshna, Madhura rasa vyavayi 118 and Saindhava is
also sukshma (subtle), ushna laghu, thus helps in easy and immediate penetration of taila
in to the body tissues 119.
Eranda taila is used for virechana which is having qualities to subside both vata
and kapha according to Sushruta 120. Bharangi and Shunti are used in different drug
combination for shwasa121-124 Bharangyadi kwatha is mentioned by Yogaratnakara 125 and
Bhaishajya ratnavali 126 for Tamaka shwasa.
Bharangyadi kwatha consists of only two drugs.
Contents
Name of the drug Latin name Quantity
1) Bharangi Clerodendrum serratum 15gm (Yavakuta churna)
2) Shunti Zingiber officinale 15gm (Yavakuta churna)
Kwatha is prepared by adding 8 times of water 127(i.e. 240ml) and reduced to one
eighth 128 (i.e.30ml). kwatha is administered in a dose of 15-20ml twice daily (morning
and evening).
Review of Literature
Page 40
BHARANGI 129
Bharangi consists of dried roots of Clerodendrum serratum (Linn) Moon (Fam.
Verbenaceae), a shrub distributed throughout the country.
Sanskrit : Angaravalli, Brahmanayastika
Hindi : Bharangee
Kannada : Gantubarangee
Marathi : Bharangee, Bharang
DESCRIPTION
Mature root hard, woody cylindrical up to 5cm thick, external surface light brown
having elongated lenticles, bark, thin and easily separated from a broad wood which
shows marked medullary rays and concentric growth rings in a transversely cut surface
fracture, short, taste, acrid.
Foreign matter : Not more than 2%
Total ash : Not more than 4%
Acid insoluble ash : Not more than 1%
Alcohol soluble extractive : Not more than 36%
Water soluble extractive : Not more than 6%
Fixed oil : Not more than 37%
CONSTITUENTS: Saponins
Rasa : Katu, Tikta, Kashaya
Guna : Laghu, Ruksha
Veerya : Ushna
Vipaka : Katu
Karma : Vatahara, Kaphahara, Deepana, Pachana,
Swasahara, Ruchya.
Review of Literature
Page 41
IMPORTANT FORMULATIONS
Ayaskrit, Kanakasava, Dashamularista, Bharangyadi kwatha churna,
Mahavatagajankusa rasa.
THERAPEUTIC USES
Gulma, Jwara, Shwasa, Kasa, Yakshma, Hikka, Raktadosha.
Dose - 3-6 gm of powder
10-20 gm of Kwatha churna
SHUNTI 130
Ardraka consists of fresh rhizome of Zingiber officinale Rose. (Fam.
Zingiberaceae); a herbaceous rhizomatous perennial; reaching up to 90cms in height,
wildly cultivated in India. Rhizomes are dug in January-February, buds and roots are
removed and washed well.
Sanskrit : Katubhadra, Shingavera.
English : Ginger.
Hindi : Adarakh.
Kannada : Alla, Hashishunthi.
Marathi : Ardrak, Ale.
DESCRIPTION
Drug occurs as entire rhizome or in pieces, rhizome laterally compressed bearing
flattish ovate, oblique branches on upper side, each having a depressed scar at its apex,
pieces 5-15cm long, 1.5-6.5cms wide (usually 3-4cms) and 1-1.5cm thick, fracture, short
with projecting fibers, transversely cut surface shows a wide central stele having
numerous grayish cut ends of fibers and yellow secreting cells, odour, gingery; taste,
pungent.
Review of Literature
Page 42
Foreign matter : not more than 0.5%.
Total ash : not more than 8%.
Acid insoluble ash : not more than 1%.
Alcohol soluble extractive : not less than 5%.
Water soluble extractive : not less than 2%.
Moisture content : not more than 90%.
CONSTITUENTS
Volatile oil containing Cineole zingiberol, and sesquiterpene like zingiberene,
bisobolene and sesqui phellandrene, gingersol in the oleo-resin.
Rasa : Katu
Guna : Teekshna, Ruksha, Guru.
Veerya : Ushna.
Vipaka : Madhura.
Karma : Vatahara, Kaphahara, Rochana, Deepana, Bhedana, Svarya,
Hridya, Vrashya.
IMPORTANT FORMULATIONS
Ardraka khandavaleha, saraswataristha.
THERAPEUTIC USES
Anaha, Vibandha, Shula, Shopha, Kantharogas.
DOSE
2-3ml of the drug in juice form with honey; 20-40ml of infusion with honey.
Review of Literature
Page 43
ERANDA 131
Eranda consists of dried seed of Ricinus communis Linn. (Fam. Euphoriaceae); a
tall glabrous shrub or almost small tree, 2-4 m high; found throughout India, mostly
growing wild on waste land and also cultivated for its oil seeds.
Sanskrit : Gandharva-Hasta, Panchangula, Vatari.
English : Castor oil plant.
Hindi : Erand, Rendee, Andeo.
Kannada : Harlu.
Marathi : Erand, Erandee.
DESCRIPTION
Castor oil is colourless or faintly yellow or straw-coloured, practically odourless, with a
bland and slightly acrid taste.
Foreign matter : not more than 2%.
Total ash : not more than 4%.
Acid insoluble ash : not more than 1%.
Alcohol soluble extractive : not less than 36%.
Water soluble extractive : not less than 6%.
Fixed oil : not less than 37%.
CONSTITUENTS
Seeds contain fixed oil 43-52%, proteins 20%, starch, mucilage, sugar and ash
10%. The oil chiefly consists of ricinoleate of glycerol, or tri-ricinolein, with small
quantity of palmatin and stearin.
Rasa : Madhura, Katu, Kashaya.
Guna : Snigdha, Teekshna, Sukshma.
Veerya : Ushna.
Vipaka : Madhura.
Review of Literature
Page 44
Karma : Deepana, Amapachana, Vidbhedana, Anulomana,
Srotoshodhana, Vayasthapana,
IMPORTANT FORMULATIONS
Brahat Saindhavadi taila, Gandharvahastayadi taila, Simhanada Guggulu,
Mishraka Sneha.
THERAPEUTIC USES
Amavata, Vibandha, Yakrit roga, Plihodara, Arsha, Katishula, Gradhrasi, Jwara,
Svasa, Kasa, Kustha.
DOSE
10-20ml (Shamanartha), 30-60ml (Shodhanartha).
Shunti is pachaka kaphaghna, vatahara 132. Being a pachaka, digest the ama,
which is root cause for disease. As it is vatahara and kaphaghna facilitates normal flow of
vata relieving obstruction.
Bharangi is having qualities like ushna, kaphaghna, vataghna, pachana,
shothahara 133. Thus helps in reducing shotha of pranavaha srotas, being vataghna,
softens the pranavaha srotas srotas also controls the over secretion of mucus, being
kaphaghna liquefies the kapha thus relieves the obstruction. Shunti and Bharangi together
are kaphavatahara, shotaghna, pachaka, thus directly acting on pranavaha srotas and also
on pittasthana (amahara). Thus the combination of these drugs are beneficial in
counteracting all the aspects of pathological process of Tamaka shwasa.
Eranda taila is told to be soumya, sramshana, dahashamaka, vatahara 134 and
according to Sushruta kaphavatahara. So it act as best virechaka dravya for Tamaka
shwasa. Snehana (Bahyabhyanga with lavanataila) and Nadiswedana helps in the
liquification of kapha dosha remove the obstruction, controls vata, bring the doshas to the
kosta. Virechana with Eranda taila which is given after snehana and swedana removes the
doshas from pittasthana. Thus Eranda taila is beneficial.
Methodology
METHODOLOGY
Following materials were taken for the clinical study
A] Drugs:
a) Deepana pachanartha : Shunti phanta
b) Snehanartha : Lavan taila
c) Shodhanartha : Eranda taila
d) Shamanartha : Bharangyadi kwath
B] Instrument:
Peak flow meter.
COLLECTION OF MATERIALS
A] Drugs:
Shunti, Eranda taila, Saidhava lavana and Tila taila Bharangi were properly
identified and purchased from Subbarao medicals Koppa.
B] Methodology of peak flow meter analysis
After preliminary examination, they were advised in detail and proper
demonstration was given regardly performing on the peak flow meter. They were advised
to attend the OPD at the time when they were symptom free and feel normal PEFR was
recorded at base line recording of particular individual. The severity and the clinical
improvement was assessed with respect to the base line PEFR, test with bronchodilator
therapy was not performed.
Method:
1. Patient was advised to relax for few minutes and to breathe normally.
2. When patient feels comfortable and becomes familiar with peak flow meter method.
Patient was advised to take a deep inspiration and to hold the mouth piece tightly
between the teeth and to fasten the lips.
Page 45
Methodology
3. Patient was advised to expire out as fast and rapidly as possible with full efforts i.e. in
the form of blast; through the mouth piece.
4. The value on the peak flow meter gauge to which the pointer indicates; corresponds
to the PEFR of that attempt.
Three trials were taken each time and the best of three readings was considered.
Shunti phana:
1 part of finely powdered Shunti was mixed to 4 times of boiling water and
allowed to cool, the mixture was filtered and stored. It was prepared a fresh every time
whenever required.
Bharangyadi kwath:
Equal quantity of Bharangi and shunti was taken and 8 times of water added
boiled and reduced it to 1/4th water. It was prepared a fresh everytime whenever required.
Lavana taila:
1 part of Finely powdered Saidhanva lavana was mixed with 4 parts of Tilataila,
the mixture was heated on mandagni allowed to cool and stored in clean, dry glass
container.
METHODS
Aim:
The aim of the study was to assess the effect of virechana and Bharangyadi kwath
in the management of Tamaka shwasa.
RESEARCH DESIGN
It is a comparative clinical study where patients suffering from Tamaka shwasa of
either sex of age group of above 15 years were selected and randomly allocated into
group A, B and C respectively.
Page 46
Methodology
Selection of the patients:
Patients visiting the OPD, A.L.N.Rao.Ayurvedic Medical College and Hospital,
Koppa; were screened and patients diagnosed as Tamaka Shwasa were selected for the
study; appropriately satisfying the selection criteria.
INCLUSION CRITERIA
1. Diagnosed patients of Tamaka shwasa.
2. Patients of Tamaka shwasa without any upadrava.
3. Patients between the age 15-65.
4. Patients fit for Snehana, Swedana and Virechana karma.
EXCLUSION CRITERIA
1. Patients below 15 and above the age 65.
2. Patients of Tamaka shwasa who are suffering form other systemic disorders like
Rajayakshma complication like emphysema, corpulmonale
3. Patients of Tamaka shwasa with secondary infections.
4. Cardiac and Renal asthma.
INTERVENTION
The three groups assigned as A, B and C; were treated with Virechana,
Bharangyadi kwath and Virechana followed by Bharangyadi kwath respectively
GROUP A: (VIRECHANA GROUP)
Patients were administered with Shunthi phanta; between 20-40ml depending on
the bala of the patient and assessing the sama/niramavastha. It was administered till
niramavastha is attained.
Sukoshna lavan taila was applied on the urapradesh and gentle massage was done;
patient was subjected for nadi sweda; taking precaution to protect the hridaya marma
from swedana process by wrapping the chest region by kadali patra. Patient was
Page 47
Methodology
administered with 15-45ml of Eranda taila depending on the kostha of the patient, with
ushna jala on empty stomach on the next day morning. After observing the samyak
virikta lakshanas; patient was advised samsarjana krama; based on the degree of
shodhana. Pathya-apathya advised according to classical consideration.
GROUP B (Bharangyadi group)
15-20 ml of Bharagyadi kwatha was administered twice daily for 1 week. The
dose was varied according the roga and rogibala. Pathya apathya advised according to
classical consideration. Patients were advised to prepare the fresh kwatha daily. They
were provided packets of Shunti and Bharangi kwatha churna.
GROUP C: (Virechana and Bharangyadi group)
The patients were subjected to virechana karma similar to the group A;
intervention, and were followed by Bharangyadi kwath similar to the intervention of
group B, after the samsarjana krama.
Patients were strictly advised to maintain the symptom dairy provided to them;
and to attend the OPD weekly; for periodic follow-up, till the end of follow-up for 1
month. They were also advised to consult immediately; if any discomfort felt in the
course of follow-up period.
SYMPTOM DIARY
A symptom diary was formatted to record the severity of the symptoms; which
was completely based on subjective feeling. The grading pattern was advised and the
recording was maintained through out the course of follow up. The purposes of
maintenance of symptom diary were;
1. To know the frequency of attacks, periodicity between the consecutive attacks and
specific time of attack.
2. To compare the severity recorded by subjective feeling and the severity graded by
fixed standards.
Page 48
Methodology
Table No. 8 Symptom dairy
SYMPTOM DIARY FOR TAMAKA SVASA (Bronchial asthma) Name Date Age OP.D. no Sex No assigned (for clinical trial) Occupation Group Address Start date End date Signature of the patient Signature of the Research Scholar
1. This is a unique method adopted for the grading of the particular symptom on the daily recording basis. 2. The grading will be purely based on subjective feelings of individual.
3. Overall grading will be compared with assessment criteria fixed as standards. INSTRUCTIONS GRADING 1. On every day morning patient has to mark grading; as he was informed. (Patients feelings about individual symptom in last 24 hours). 2. In case of confusion/unable to record; put “X” mark against individual symptom on that particular day.
3. Patient has to bring the diary for weekly visit as well as visits in between (if needed).
SEVERITY GRADE
4. Prakrita 1 5. Mridu 2 6. Madhyama 3 7. Teevra 4 Sl.No. Day
Symptom
01 02 03 04 05 Up to 30th
Total score (T)
T/N
1. Svasakrichrata 2. Kasa 3. Dhurdhuraka 4. Nidra 5. Vyayama
Page 49
Methodology
Assessment of the following variables for there severity in six concluding visits mentioned in the table.
SL. no VARIABLES BT AT I W II W III W FU 1. Svasakrichrata 2. Kasa 3. Dhurdhuraka 4. Nidra 5. Vyayama BT = Before Treatment AT = After Treatment W = Week FU = end of Follow Up At the end of 30th day; score for individual symptoms are summed and assigned for the degree of severity; with the help of score ranges. Score ranges (Total scoring divided by number of recordings). = T ÷ N The remarks are given on the basis of relief in degrees as A Excellent = 3 degree reduction in severity B Good = 2 degree reduction in severity C Encouraging = 1 degree reduction in severity D Stable = Disease status remains same E Deteriorated = Increase in the degree of severity SYMPTOM SCORE SEVERITY REMARKS OVERALL
ASSESSEMENT T ÷ N BT FU Svasakrichrata SEVERITY RANGE Kasa Prakrita 0-1 Dhurdhuraka Mridu 1-2 Nidra Madhyama 2-3 Vyayama Teevra 3-4 ASSESSMENT OF VARIABLES
Clinical assessment was made for the severity of the disease and for the clinical
improvement. Grading for the severity of individual symptom as well as for over all
assessment was framed as four point scale (1-4) on the basis of; guidelines on the
management steps of Asthma; British Thoracic Society. The grading of 9 variables is
given along with clinical proforma especially formatted for the study on Tamaka shwas.
The severity of each variable ranging from Prakrita(1), Mridu(2), Madhyama(3) and
Teevra(4).
Page 50
Methodology
Table No. 9 GRADING FOR THE ASSESSEMENT OF SEVERITY OF
TAMAKA SVASA (Bronchial Asthma)
Scorings Prakrata (1) Mridu (2) Madhyama (3) Daruna (4) Assessment for
Svasakrichrata Attack per week
Attack free One attack 2-4 attacks More than 4 attacks
Svasakrichrata Duration
Attack free Brief for minutes
Prolonged for 2-3 hours
Almost continuous
Kasa Absent Relieved by expectoration
Relieved by treatment
Persistent
Svasakrichrata (on speech)
Normal speech
Speaks in sentences for short period
Speaks in phrases or partial sentences
Speaks only in single words or short phrases
Dhur-dhuraka Wheeze absent
End expiratory wheeze only
Wheeze during entire expiration and inspiration
Breath sounds becoming inaudible/ silent chest
Nidra Normal Difficult in getting sleep
Disturbed at the time of attacks
Disturbed at the time of attacks (Frequent)
Vyayama Normal Perform lightly
Reduced Unable
Prajna Normal Varied Confused Loss of consciousness
PEFR More than 90% predicted
70-90% predicted
50-70% predicted
Less than 50% predicted
OVERALL ASSESSMENT OF SEVERITY
Based on the scoring of variables, overall severity was graded as:
Prakrita 00-09
Mridu 10-18
Madhyama 19-27
Teevra 28-36
LABORATORY INVESTIGATIONS
Following investigations were performed; before and after treatment and at the
end of follow-up; to assess the severity and clinical improvement respectively.
Blood: Hb%, TLC, DLC, ESR, AEC.
Sputum: Eosinophils.
Page 51
Methodology
In suspected cases Sputum AFB, Chest X-ray and ECG were performed to rule out,
pulmonary tuberculosis, other pulmonary diseases and cardiac involvement.
ASSESSMENT OF CLINICAL IMPROVEMENT
Clinical improvement of the disease was based on:
Reduction in the severity of the symptom, overall severity of the disease and
improvement in laboratory findings. Grading for clinical improvement individual
symptom and overall severity is as,
Grading for clinical improvement for individual symptom
1. CD : Clinically determined i.e. increase in severity score against the initial score.
2. CS : Clinically stable i.e. severity score remains same as the initial score.
3. CI-1- Encouraging i.e. 1 degree reduction in the severity score against the initial score
i.e. reduction from mild-normal, moderate-mild and severe-moderate.
4. CI-2- Good i.e. 2 degree reduction in the severity score against the initial score. Ex.-
severe-mild.
5. CI-3- Excellent, 3 degree reduction in the severity score against the initial score,
reduction from severe-normal.
Grading for clinical improvement on overall severity
1. C-D- Deteriorate (increase in the severity score).
2. C-S - Stabilized (no change in the severity score).
3. CI-1- Encouraging (9 degree reduction in the severity score from initial score).
4. CI-2- Good (18 degree reduction in the severity score from initial score).
5. CI-3- Excellent (27 degree reduction in the severity score from initial score).
DATA COLLECTION
Weekly assessment for individual symptom and over-all clinical assessment was
done. The data was collected from each group at the end of follow-up and scoring was
done and finally the data was compared and analysed statistically.
Laboratory investigations were done before treatment, after treatment and at the
end of the follow-up period for 1 month.
Page 52
Results
OBSERVATIONS AND RESULTS
In the present study 36 patients suffering from Tamaka shwasa fulfilling the
inclusion criteria were selected and registered. Out of which 6 patients failed to complete
the study for different non medical reasons. The remaining patients were randomly
categorized into group A, B and C.
Following contains the detail explanation along with
Observation of the over all patients.
The detail statistical analysis of the symtomatology before and after treatment in
three groups.
Comparative statistical analysis of the results in between three groups.
OBSERVATIONS
Analysis of age incidence of the 30patients suffering from Tamaka shwasa
showed more number of patients between the age group of 20-30 yrs (36.67%).
Details of the age incidence is given in table below.
Table No. 10 Distribution of patients according to Age groups:
AGE GROUP No of Patients % 10-20 yrs 07 23.33 20-30 yrs 11 36.67 30-40 yrs 04 13.33 40-50 yrs 03 10.00 50-60 yrs 05 16.67
Fig No-1 INCIDENCE OF AGE
0%
37%13%
10%17%
23%00-10 yrs10-20 yrs20-30 yrs30-40 yrs40-50 yrs50-60 yrs
Page 53
Results
In the sample taken for the study 60% of males were registered in comparison to
40% to females table shows the details.
Distribution of patients according to sex
Table No.11
SEX GROUP No of Patients % MALE 18 60
FEMALE 12 40
Fig No – 2 SEX INCIDENCE
60%
40%
MALE FEMALE
SOCIO ECONOMIC STATUS:
In the present study maximum number of patients were belongs to the middle
class i.e. 50%. Upper class were (12 pts, 40%) lower class were (2 pts, 6.67%) lower
middle class were (1pt 3.33%).
Table No.12
ECONOMICAL STATUS No of Patients % UPPER CLASS 12 40.00
MIDDLE CLASS 15 50.00 LOWER MIDDLE CLASS 01 03.33
LOWER CLASS 02 06.67
Page 54
Results
Fig No – 3 INCIDENCE OF ECONOMICAL
STATUS
40%7%3%
50%UPPER CLASS MIDDLE CLASSLOWER MIDDLE CLASS LOWER CLASS
EDUCATION:
Most of the patients were educated up to graduation 12pts (40%). Patients
educated up to PUC were 12 pts, 40.00%. Patients up to primary were 4pts 13.33%.
Table No.13
EDUCATION No of Patients % PRIMARY 04 13.33
PUC 12 40.00 GRADUATION 12 40.00
POST GRADUATION 02 06.66
Fig No – 4 INCIDENCE OF EDUCATION
4, 13%
12, 40%12, 40%
2, 7%
PRIMARY PUC
GRADUATIO N PO ST GRADUATIO N
Page 55
Results
FOOD HABITS
In the present study it was observed that vegetarian were (14pts, 46.67%), mixed
were (16 pts, 53.33%).
Table No.14
DIET No of Patients % VEGETERIAN 14 46.67
MIXED 16 53.33
Fig No.5
INCIDENCE OF DIET
47%
53%
VEGETERIN MIXED
AGNI
Patients registered for the study were assessed for samagni, mandagni,
teekshnagni and vishamagni. Majority of patients were presenting with mandagni (17pts,
56.67%), teekshnagni (7pts, 23.33%), vishamagni (6pts, 20%). None of the patient was
with samagni.
Table No.15
AGNI No of Patients % MANDA 17 56.67
TEEKSHNA 07 23.33 VISHAMA 06 20.00
Page 56
Results
Page 57
INCIDINCE OF AGNI
57%23%
20%
Manda Teekshna Vishama
INCIDENCE OF PRAKARTIVP
27%
VK46%
PK27%
VP
VK
PK
Fig No – 6
DISTRIBUTIONS OF PATIENTS ACCORDING TO PRAKARTI
The patients registered for the study were assessed to be of dwandwaja prakrati;
among which majority of patients were of vatakaphaja (14pts, 46.66%), vatapittaja (8pts,
26.67%) and pittakaphaja (8pts, 26.67%).
Table No.16
PRAKARTI No of Patients % VATAPITTAJA (VP) 08 26.67
VATAKAPHAJA (VK) 14 46.66 PITTAKAPHAJA (PK) 08 26.67
Fig No – 7
Results
KOSTHA
Patients registered for the study were assessed for mridu, madhyama and krura
kostha. Majority of patients were with krura kostha (13pts, 43.33%), madhyama kostha
(9pts, 30%) and mridu kostha (8pts, 26.67%).
Table No.17
KOSTHA No of Patients % MRUDU 08 26.67
MADHYAMA 09 30.00 KRURA 13 43.33
Fig No – 8 INCIDENCE OF KOSTHA
8, 27%
9, 30%
13, 43%
MRIDU MADHYAMA KRURA
SATWA:
In the present study patients of madhyama satwa (14pts, 46.67%), avara satwa
(12pts, 40%) and pravara satwa (4pts, 13.33%).
Table No.18
SATWA No of Patients % PRAVARA 04 13.33
MADHYAMA 14 46.67 AVARA 12 40.00
Page 58
Results
Page 59
INCIDENCE OF HABITAT
14, 47%16, 53%
URBAN RURAL
INCIDENCE OF SATWA
12, 40%
4, 13%
14, 47%
PRAVARA MADHYAMA AVARA
Fig No – 9
HABITAT Patients registered for the study were nearly evenly distributed regarding their
habitat, i.e. belonging to urban area (16pts, 53.33%) and belonging to rural area (14pts,
46.67%).
Table No.19
HABITAT No of Patients % RURAL 14 46.67 URBAN 16 53.33
Fig No – 10
Results
CHRONICITY
In the present study the chronicity of the disease was categorised as 0-5 yrs, 6-10
yrs, 11-15 yrs and 16-20 yrs (inclusive). Majority of patients belonging to 0-5 yrs (17pts,
56.67%), patients with 6-10 yrs were (9pts, 30%), patients with 16-20 yrs were (3pts,
10%) and patient with 11-15 yrs was (1pt, 3.33%).
Table No.20
CHRONICITY No of Patients % 00-05 yrs 17 56.67 06-10 yrs 09 30.00 11-15 yrs 01 03.33 16-20 yrs 03 10.00
Fig No – 11 INCIDENCE OF CHRONICITY
30%
3%10%
57%
00-05 yrs
06-10 yrs
11-15 yrs
16-20 yrs
RELATION TO FOOD
In the present study it was observed that patients presenting with positive
response for variation of the disease status with relation to food were (20pts, 66.67%), no
response were (10pts, 33.33%)
Table No.21
RELATION TO FOOD No of Patients % PRESENT 20 66.67 ABSENT 10 33.33
Page 60
Results
Page 61
INCIDENCE OF SLEEP PATTERN
30% 30%
13%27%NORMALDIFFICULTY IN GETTING SLEEPDISTURBED AT THE TIME OF ATTACKDISTURBED FREQUENTLY
INCIDENCE SHOWING RELATION WITH FOOD
PRESENT ABSENT
Fig No – 12
NIDRA
In the present study it was observed that patients with normal sleep were (9pts,
30%), with frequently disturbed sleep were (9pts, 30%), with disturbed sleep at the time
of attack were (8pts, 26.67%) and patients with difficulty in getting sleep were (4pts,
13.33%).
Table No.22
SLEEP PATTERN No of Patients % NORMAL 09 30.33
DIFFICULTY IN GETTING SLEEP 04 13.33 DISTURBED AT THE TIME OF ATTACK 08 26.66
DISTURBED FREQUENTLY 09 30.00
Fig No – 13
Results
RELATION TO EXERCISE
In the present study patient in whoom exercise have no effect in causing the
disease attack were (14 pts 46.67%) in whoom causes attack were (16 pts 53.33%).
Table No.23
RELATION TO EXERCISE No of Patients % PRESENT 14 46.67 ABSENT 16 53.33
Fig No – 14 INCIDENCE SHOWING
RELATION WITH EXERCISE
14, 47%
16, 53%
PRESENT ABSENT
RELATION TO CLIMATE
In the present study patients presenting with no response to climatic changes
influencing the disease status were (16pts, 53.33%) and patients positively responding to
the climatic changes were (14pts, 46.66%).
Table No.24
RELATION TO CLIMATE No of Patients % PRESENT 16 53.33 ABSENT 14 46.67
Page 62
Results
Fig No – 15
INCIDENCE RELATION TO CLIMATE
PRESENT, 16, 53%
ABSENT, 14, 47%
PRESENT ABSENT
SMOKING
In the present study it was observed that non smokers were (20pts, 66.66%) and
smokers were (10pts, 33.33%).
Table No.25
SMOKING No of Patients % SMOKERS 10 33.33
NON SMOKERS 20 66.66
Fig No – 16 INCIDENCE OF SMOKING
33%
67%
SMOKERS NON SMOKERS
Page 63
Results
ALCHOHOL
In this study 8 patients (26.677) were alcohol consumers and non consumers 22
patients (73.33%).
TOBACCO CHEWING
In the present study it was observed that non tobacco chewers were (21pts, 70%)
and tobacco chewers were (9pts, 30%).
DISTRIBUTION OF PATIENTS ACCORDING TO SIGNS AND SYMPTOMS
1) PRATISHYAYA
In the present study it was observed that the patients associated with pratishyaya
at the time of attack were (20pts, 66.66%) and not associated with pratishyaya at the time
of attack were (10pts, 33.33%).
2) TIGHTNESS IN THE CHEST
In the present study it was observed that the patients presenting with chest
tightness at the onset of an episode were (23pts, 76.66%) patients presenting with vague
discomfort in the chest and unable to distinguish it as chest tightness were (2pts, 6.66%)
patients without chest tightness were (5pts 16.66%)
3) NIDRA
Patients with this work with normal sleep were (9pts, 30%), with frequently
disturbed sleep were (9pts, 30%), with disturbed sleep at the time of attack were (8pts,
26.66%) and patients with difficulty in getting sleep were (4pts, 13.33%).
4) SHWASAKRICHRATA
Shwasakrichrata was graded as mridu, madhyama and teevra. Patients with mridu
grade were (13pts, 43.33%), madhyama grade were (13pts, 43.33%) and with teevra
grade were (4pts, 13.33%).
Page 64
Results
5) DURATION OF SHWASAKRICHRATA
Patients with 10-60mins of duration of Shwasakrichrata were (14pts, 46.66%),
with 1-4hrs of duration of shwasakrichrata were (9pts, 30%) and patients with more than
4hrs duration of shwasakrichrata were (7pts, 23.33%).
6) GHURGHURAKA
In the present study ghurghuraka was graded as mridu, madhyama and teevra.
Patients with mridu grade were (12pts, 40%), madhyama grade were (10pts, 33.33%) and
with teevra grade were (8pts, 26.66%).
7) KASA
In this clinical work kasa was graded as mridu, madhyama and teevra. Patients
with madhyama grade were (10pts, 33.33%), with teevra grade were (8pts, 26.66%) with
and with mridu grade were (5pts, 16.66%) patient without Kasa (Prakrita) were (7 pts
23.33%)
8) PRAJNA
In the present study it was observed that patients with confused state of
consciousness at the time of attack were (13pts, 43.33%), with normal state of
consciousness were (9pts, 30%) and patients with varied state of consciousness were
(8pts, 26.66%).
9) OVER ALL SEVERITY
In this study it was observed that patients affected moderately were (21pts, 70%),
affected mildly were (5pts, 16.66%) and affected severely were (4pts, 13.33%).
OBSERVATIONS FOR INDIVIDUAL GROUPS
OBSERVATIONS (GROUP A)
1. All the patients were presenting with varied degree of sama lakshanas.
2. Patients received Shunti Phanta; twice daily in a dose of 20-40ml till niramavastha.
The mean dosage (each dose) was calculated to be 38ml.
Page 65
Results
3. It was observed that the duration taken to attain niramavastha was 2-4 days, with a
mean duration of 2.5 days.
4. Patients received Eranda taila in a dose of 15-45ml (single dose), with a mean dose of
28.5ml.
5. It was observed that 9-22 vegas were required to attain shuddhi lakshanas, with mean
of 15.7 vegas.
6. The time required for the onset of vega was between 90-150mins (rounded to nearest
one), with a mean time of 111mins.
7. Number of vegas in the 1st hour after the onset of the vega, were 5-13, with a mean of
9.7 vegas.
8. Samsarjana krama was performed for 3-5 days with a mean of 4.4 days.
9. It was observed that 8-11 days were required for the completion of intervention, with
a mean of 8.9 days.
(GROUP B)
1. In this group all patients were having sama lakshanas.
2. Patients received Bharangyadi kwath 15-20ml twice daily for 1 week with a mean of
17ml.
(GROUP C)
1. All the patients were presenting with varied degree of sama lakshanas.
2. Patients received shunti phanta; twice daily in a dose of 20-40ml till niramavastha
with a mean of 32ml.
3. It was observed that the duration taken to attain niramavastha was 2-4 days, with a
mean duration of 2.7 days.
4. Patients received Eranda taila in a dose of 15-45ml (single dose), with a mean dose of
31.5ml.
5. It was observed that 8-22 vegas were required to attain shuddhi lakshanas, with mean
of 15.2 vegas.
Page 66
Results
6. The time required for the onset of vega was between 90-120mins (rounded to nearest
one), with a mean time of 103.5mins.
7. Number of vegas in the 1st hour after the onset of the vega, were 4-13, with a mean of
9.2 vegas.
8. Samsarjana krama was performed for 3-5 days with a mean of 4.2 days.
9. Patients received Bharangyadi kwath 15-20ml twice daily for 1 week with a mean of
34ml.
RESULTS RELATED OBSERVATIONS FOR INDIVIDUAL GROUPS
GROUP A RESULTS (at the end of treatment)
EXCELLENT
30% (for kasa) and 10% (for nidra) patients showed excellent response at the end
of treatment.
GOOD
10% (for shwasakrichrata), 30% (for ghurghuraka), 40% (for kasa), 20% (for
shwasakrichrata {duration}), 20% (for nidra), 40% (for prajna), 20% (for shwasakrichrata
{speech}), 10% (for vyayama) and 30% (over all severity) patients showed good
response at the end of treatment.
ENCOURAGING
30% (for shwasakrichrata), 20% (for ghurghuraka), 10% (for kasa), 40% (for
shwasakrichrata {duration}), 40% (for nidra), 20% (for prajna), 60% (for shwasakrichrata
{speech}), 70% (for vyayama), 60% (PEFR) and 60% (over all severity) patients showed
encouraging response at the end of treatment.
STABLE
60% (for shwasakrichrata), 50% (for ghurghuraka), 10% (for kasa), 40% (for
shwasakrichrata {duration}), 20% (for nidra), 30% (for prajna), 20% (for shwasakrichrata
Page 67
Results
{speech}), 20% (for vyayama) and 40% (PEFR) patients showed no response at the end
of treatment.
10% patients showed increase in the severity of the kasa, nidra, prajna and over
all severity scores at the end of treatment.
GROUP B RESULTS (at the end of treatment)
EXCELLENT
20% (for ghurghuraka), 30% (for kasa), 10% (for shwasakrichrata {duration})
and 40% (for nidra) patients showed excellent response at the end of treatment.
GOOD
30% (for shwasakrichrata), 10% (for ghurghuraka), 30% (for kasa), 20% (for
shwasakrichrata {duration}), 20% (for nidra), 20% (for prajna), 30% (for shwasakrichrata
{speech}), 30% (for vyayama) and 80% (over all severity) patients showed good
response at the end of treatment.
ENCOURAGING
60% (for shwasakrichrata), 50% (for ghurghuraka), 20% (for kasa), 30% (for
shwasakrichrata {duration}), 40% (for prajna), 60% (for shwasakrichrata {speech}), 40%
(for vyayama), 70% (PEFR) and 20% (over all severity) patients showed encouraging
response at the end of treatment.
STABLE
10% (for shwasakrichrata), 20% (for ghurghuraka), 20% (for kasa), 40% (for
shwasakrichrata {duration}), 40% (for nidra), 30% (for prajna), 10% (for shwasakrichrata
{speech}) and 30% (PEFR) patients showed no response at the end of treatment.
GROUP C RESULTS (at the end of treatment)
EXCELLENT
20% (for kasa), 10% (for shwasakrichrata {duration}) and 20% (for nidra)
patients showed excellent response at the end of treatment.
Page 68
Results
GOOD
20% (for shwasakrichrata), 50% (for ghurghuraka), 30% (for kasa), 20% (for
shwasakrichrata {duration}), 20% (for nidra), 60% (for prajna), 10% (for shwasakrichrata
{speech}), 40% (for vyayama) and 70% (over all severity) patients showed good
response at the end of treatment.
ENCOURAGING
50% (for shwasakrichrata), 40% (for ghurghuraka), 20% (for kasa), 30% (for
shwasakrichrata {duration}), 30% (for nidra), 20% (for prajna), 60% (for shwasakrichrata
{speech}), 50% (for vyayama), 70% (PEFR) and 30% (over all severity) patients showed
encouraging response at the end of treatment.
STABLE
30% (for shwasakrichrata), 10% (for ghurghuraka), 30% (for kasa), 40% (for
shwasakrichrata {duration}), 30% (for nidra), 20% (for prajna), 30% (for shwasakrichrata
{speech}), 10% (for vyayama) and 30% (PEFR) patients showed no response at the end
of treatment.
Table No. 26 THE RESPONSE OF THE THERAPIES FOR INDIVIDUAL GROUP
(PERCENTAGE) AFTER TREATMENT
Variable GROUP CD CS CI-1 CI-2 CI-3
A 0% 60% 30% 10% 0% B 0% 10% 60% 30% 0% Shwasakrichrata
C 0% 30% 50% 20% 0% A 0% 50% 20% 30% 0% B 0% 20% 50% 10% 20% Ghurghuraka
C 0% 10% 40% 50% 0% A 10% 10% 10% 40% 30% B 0% 20% 20% 30% 30% Kasa
C 0% 30% 20% 30% 20% A 0% 40% 40% 20% 0% B 0% 40% 30% 20% 10% Shwasakrichrata (Duration)
C 0% 40% 30% 20% 10%
Page 69
Results
A 10% 20% 40% 20% 10% B 0% 40% 0% 20% 40% Nidra
C 0% 30% 30% 20% 20% A 10% 30% 20% 40% 0% B 0% 30% 40% 30% 0% Prajna
C 0% 20% 20% 60% 0% A 0% 20% 60% 20% 0% B 0% 10% 60% 30% 0% Shwasakrichrata (Speech)
C 0% 30% 60% 10% 0% A 0% 20% 70% 10% 0% B 0% 0% 40% 60% 0% Vyayama
C 0% 10% 50% 40% 0% A 0% 40% 60% 0% 0% B 0% 30% 70% 0% 0% PEFR
C 0% 30% 70% 0% 0% A 10% 0% 60% 30% 0% B 0% 0% 20% 80% 0% Over all
C 0% 0% 30% 70% 0%
OVER ALL RESPONSE AT THE END OF TREATMENT
Graph No. 1
1 0
63
0 002
8
0 0 03
7
0 1 0
11
18
00
5
10
15
20
group A group B group C total
Over all response at the end of treatment
C-D C-S CI-1 CI-2 CI-3
Page 70
Results
Page 71
0
6
10 01
30 0
3 20 0
10
6
00
5
10
15
group A group B group C total
Response on Svasakrichrata at the end of treatment
C-D C-S CI-1 CI-2 CI-3
0
53
0 02 120 1
5
0 0
8 9
2
0
5
10
15
group A group B group C total
Response on Ghurghuraka at the end of treatment
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON SHWASAKRICHRATA AT THE END OF TREATMENT
Graph No. 2
RESPONSE ON GHURGHURAKA AT THE END OF TREATMENT
Graph No. 3
Results
Page 72
1 1
43
02
33
0
3 3 2 1
6
108
02468
10
group A group B group C total
Response on Kasa at the end of treatment
C-D C-S CI-1 CI-2 CI-3
0
4 2
0 04
21 0
42 1 0
12
6
2
0
5
10
15
group A group B group C total
Response on Svasakrichrata (Duration) at the end of treatment
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON KASA AT THE END OF TREATMENT
Graph No. 4
RESPONSE ON DURATION OF SHWASAKRICHRATA AT THE END OF
TREATMENT
Graph No. 5
Results
Page 73
12 2
1 0
42
4
0
32 2 1
9
6 7
02468
10
group A group B group C total
Response on Nidra at the end of treatment
C-D C-S CI-1 CI-2 CI-3
13 4
0 03 3
0 02
6
0 1
8
13
00
5
10
15
group A group B group C total
Response on Prajna at the end of treatment
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON NIDRA AT THE END OF TREATMENT
Graph No. 6
RESPONSE ON PRAJNA AT THE END OF TREATMENT
Graph No. 7
Results
Page 74
02 2
0 013
0 03
1 0 0
6 6
00
5
10
15
20
group A group B group C total
Response on Svasakrichrata (Speech) at the end of treatment
C-D C-S CI-1 CI-2 CI-3
02 10 00
6
0 0 14
0 03
11
00
5
10
15
20
group A group B group C total
Response on Vyayama at the end of treatment
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON SHWASAKRICHRATA ON SPEECH AT THE END OF
TREATMENT
Graph No. 8
RESPONSE ON VYAYAMA AT THE END OF TREATMENT
Graph No. 9
Results
Page 75
04
0 0 03
0 0 03
0 0 0
10
0 00
5
10
15
20
group A group B group C total
Response on PEFR at the end of treatment
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON PEFR AT THE END OF TREATMENT
Graph No. 10
GROUP A RESULTS (at the end of follow up)
EXCELLENT
30% (for kasa) and 10% (for nidra) patients showed excellent response at the end
of follow up.
GOOD
10% (for shwasakrichrata), 30% (for ghurghuraka), 40% (for kasa), 20% (for
shwasakrichrata {duration}), 20% (for nidra), 40% (for prajna), 20% (for shwasakrichrata
{speech}), 10% (for vyayama) and 30% (over all severity) patients showed good
response at the end of follow up.
ENCOURAGING
30% (for shwasakrichrata), 20% (for ghurghuraka), 10% (for kasa), 40% (for
shwasakrichrata {duration}), 40% (for nidra), 20% (for prajna), 60% (for shwasakrichrata
{speech}), 70% (for vyayama), 60% (PEFR) and 60% (over all severity) patients showed
encouraging response at the end of follow up.
Results
STABLE
60% (for shwasakrichrata), 50% (for ghurghuraka), 10% (for kasa), 40% (for
shwasakrichrata {duration}), 20% (for nidra), 30% (for prajna), 20% (for shwasakrichrata
{speech}), 20% (for vyayama) and 40% (PEFR) patients showed no response at the end
of follow up.
10% patients showed increase in the severity of the kasa, nidra, prajna and over
all severity scores at the end of follow up.
GROUP B RESULTS (at the end of follow up)
EXCELLENT
20% (for ghurghuraka), 30% (for kasa), 10% (for shwasakrichrata {duration})
and 40% (for nidra) patients showed excellent response at the end of follow up.
GOOD
30% (for shwasakrichrata), 10% (for ghurghuraka), 30% (for kasa), 20% (for
shwasakrichrata {duration}), 20% (for nidra), 30% (for prajna), 30% (for shwasakrichrata
{speech}), 60% (for vyayama) and 80% (over all severity) patients showed good
response at the end of follow up.
ENCOURAGING
60% (for shwasakrichrata), 50% (for ghurghuraka), 20% (for kasa), 30% (for
shwasakrichrata {duration}), 40% (for prajna), 60% (for shwasakrichrata {speech}), 40%
(for vyayama), 70% (PEFR) and 20% (over all severity) patients showed encouraging
response at the end of follow up.
STABLE
10% (for shwasakrichrata), 20% (for ghurghuraka), 20% (for kasa), 40% (for
shwasakrichrata {duration}), 40% (for nidra), 30% (for prajna), 10% (for shwasakrichrata
{speech}) and 30% (PEFR) patients showed no response at the end of follow up.
Page 76
Results
GROUP C RESULTS (at the end of follow up)
EXCELLENT
20% (for kasa), 10% (for shwasakrichrata {duration}) and 20 % (for nidra)
patients showed excellent response at the end of follow up.
GOOD
20% (for shwasakrichrata), 50% (for ghurghuraka), 30% (for kasa), 20% (for
shwasakrichrata {duration}), 20% (for nidra), 60% (for prajna), 10% (for shwasakrichrata
{speech}), 40% (for vyayama) and 70% (over all severity) patients showed good
response at the end of follow up.
ENCOURAGING
50% (for shwasakrichrata), 40% (for ghurghuraka), 20% (for kasa), 30% (for
shwasakrichrata {duration}), 30% (for nidra), 20% (for prajna), 60% (for shwasakrichrata
{speech}), 50% (for vyayama), 70% (PEFR) and 30% (over all severity) patients showed
encouraging response at the end of follow up.
STABLE
30% (for shwasakrichrata), 10% (for ghurghuraka), 30% (for kasa), 40% (for
shwasakrichrata {duration}), 30% (for nidra), 20% (for prajna), 30% (for shwasakrichrata
{speech}), 10% (for vyayama) and 30% (PEFR) patients showed no response at the end
of follow up.
Page 77
Results
Table No. 27 THE RESPONSE OF THE THERAPIES FOR INDIVIDUAL
GROUP (PERCENTAGE) AT THE END OF FOLLOW
Variable GROUP CD CS CI-1 CI-2 CI-3
A 0% 60% 30% 10% 0% B 0% 10% 60% 30% 0% Shwasakrichrata
C 0% 30% 50% 20% 0% A 0% 50% 20% 30% 0% B 0% 20% 50% 10% 20% Ghurghuraka
C 0% 10% 40% 50% 0% A 10% 10% 10% 40% 30% B 0% 20% 20% 30% 30% Kasa
C 0% 30% 20% 30% 20% A 0% 40% 40% 20% 0% B 0% 40% 30% 20% 10% Shwasakrichrata (Duration)
C 0% 40% 30% 20% 10% A 10% 20% 40% 20% 10% B 0% 40% 0% 20% 40% Nidra
C 0% 30% 30% 20% 20% A 10% 30% 20% 40% 0% B 0% 30% 40% 30% 0% Prajna
C 0% 20% 20% 60% 0% A 0% 20% 60% 20% 0% B 0% 10% 60% 30% 0% Shwasakrichrata (Speech)
C 0% 30% 60% 10% 0% A 0% 20% 70% 10% 0% B 0% 0% 40% 60% 0% Vyayama
C 0% 10% 50% 40% 0% A 0% 40% 60% 0% 0% B 0% 30% 70% 0% 0% PEFR
C 0% 30% 70% 0% 0% A 10% 0% 60% 30% 0% B 0% 0% 20% 80% 0% Over all
C 0% 0% 30% 70% 0%
Page 78
Results
Page 79
10 0 00 0 00 0 10 005
101520
number
group A group B group C total
Over all response at the end of follow up
C-D C-S CI-1 CI-2 CI-3
0
6
0 01 0 03
0 0
10
00
5
10
15
number
group A group B group C total
Response on Svasakrichrata at the end of follow up
C-D C-S CI-1 CI-2 CI-3
OVER ALL RESPONSE AT THE END OF THE FOLLOW UP
Graph No. 11
RESPONSE ON SHWASAKRICHRATA AT THE END OF THE FOLLOW UP
Graph No. 12
Results
Page 80
0
5
0 02 2
0 1 0 0
8
2
0
5
10
15
number
group A group B group C total
Response on Ghurghuraka at the end of follow up
C-D C-S CI-1 CI-2 CI-3
1 13
02
3
0
32 1
68
02468
10
number
group A group B group C total
Response on Kasa at the end of follow up
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON GHURGHURAKA AT THE END OF THE FOLLOW UP
Graph No. 13
RESPONSE ON KASA AT THE END OF THE FOLLOW UP
Graph No. 14
Results
Page 81
0
4
0 0
41 0
4
1 0
12
2
0
5
10
15
number
group A group B group C total
Response on Svasakrichrata (Duration) at the end of follow up
C-D C-S CI-1 CI-2 CI-3
12 1 0
4 4
0
32 1
97
02468
10
number
group A group B group C total
Response on Nidra at the end of follow up
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON DURATION OF SHWASAKRICHRATA AT THE END OF THE
FOLLOW UP
Graph No. 15
RESPONSE ON NIDRA AT THE END OF THE FOLLOW UP
Graph No. 16
Results
Page 82
1 30 0
30 0
20 1
8
00
5
10
15
number
group A group B group C total
Response on Prajna at the end of follow up
C-D C-S CI-1 CI-2 CI-3
0 20 01 0 0
30 0
60
0
5
10
15
20
number
group A group B group C total
Response on Svasakrichrata (speech) at the end of follow up
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON PRAJNA AT THE END OF THE FOLLOW UP
Graph No. 17
RESPONSE ON SHWASAKRICHRATA ON SPEECH AT THE END OF THE
FOLLOW UP
Graph No. 18
Results
Page 83
0 20 00 0 0 1 0 0
30
0
5
10
15
20
number
group A group B group C total
Response on Vyayama at the end of follow up
C-D C-S CI-1 CI-2 CI-3
04
0 03
0 03
0 0
10
00
5
10
15
20
number
group A group B group C total
Response on PEFR at the end of follow up
C-D C-S CI-1 CI-2 CI-3
RESPONSE ON VYAYAMA AT THE END OF THE FOLLOW UP
Graph No. 19
RESPONSE ON PEFR AT THE END OF THE FOLLOW UP
Graph No. 20
Results
Table No. 28 STATISTICAL ANALYSIS OF GROUP A RESULTS
Variable Grading on Mean SD SE t P value Significance
BT 2.6 0.68 0.20 AT 2.1 0.47 0.16 6.13 0.0019 Significant Shwasakrichrata FU 2.0 0.00 0.00 1.95 0.0112 NS BT 2.9 0.86 0.26 AT 1.8 0.41 0.14 8.41 0.0003 HS Ghurghuraka FU 2.2 0.01 0.003 5.66 0.0023 S BT 2.7 1.09 0.35 AT 1.7 0.48 0.14 6.04 0.0016 S Kasa FU 1.3 0.39 0.14 2.48 0.056 NS BT 2.9 0.73 0.24 AT 1.7 0.41 0.14 5.71 0.0022 S Shwasakrichrata
(Duration) FU 2.1 0.00 0.00 2.88 0.0334 NS BT 2.8 1.08 0.34 AT 1.7 0.65 0.21 1.89 0.1350 NS Nidra FU 1.8 0.54 0.17 3.16 0.146 NS BT 2.1 0.90 0.28 AT 1.4 0.45 0.15 3.80 0.123 NS Prajna FU 1.2 0.30 0.09 7.95 0.0004 HS BT 2.7 0.45 0.14 AT 1.7 0.48 0.16 8.58 0.0004 HS Shwasakrichrata
(Speech) FU 1.6 0.49 0.16 8.60 0.0004 HS BT 2.8 0.40 0.13 AT 1.9 0.31 0.10 7.69 0.0006 HS Vyayama FU 2.0 0.30 0.10 5.62 0.0025 S BT 2.7 0.50 0.16 AT 2.0 0.29 0.08 7.66 0.0006 HS PEFR FU 2.1 0.00 0.00 11.23 0.0001 HS BT 22.9 3.28 1.06 AT 15.7 1.88 0.60 3.23 0.0270 NS Over all FU 15.9 1.15 0.39 3.24 0.0270 NS
Page 84
Results
Table No. 29 STATISTICAL ANALYSIS OF GROUP B RESULTS
Variable Grading on Mean SD SE t P value Significance
BT 2.8 0.69 0.23 AT 1.9 0.56 0.16 11.21 0.0001 HS Shwasakrichrata FU 1.6 0.47 0.15 11.23 0.0001 HS BT 2.9 0.86 0.29 AT 2.0 0.31 0.08 4.82 0.0049 S Ghurghuraka FU 1.6 0.50 0.17 7.05 0.0008 S BT 2.6 1.02 0.36 AT 1.6 0.60 0.14 8.17 0.0005 HS Kasa FU 1.1 0.00 0.00 7.72 0.0006 HS BT 2.8 0.80 0.30 AT 1.9 0.40 0.14 6.65 0.0004 HS Shwasakrichrata
(Duration) FU 1.8 0.47 0.15 6.63 0.0004 S BT 2.7 1.25 0.46 AT 1.3 0.50 0.19 5.64 0.0003 S Nidra FU 1.2 0.01 0.01 5.48 0.0004 S BT 2.2 0.76 0.23 AT 1.3 0.40 0.08 5.91 0.0019 S
Prajna FU 1.2 0.00 0.00 6.08 0.0018 S BT 2.4 0.45 0.14 AT 1.8 0.50 0.16 5.71 0.0025 S Shwasakrichrata
(Speech) FU 1.3 0.32 0.09 11.18 0.0001 HS BT 2.7 0.51 0.16 AT 1.5 0.51 0.16 5.70 0.0025 S Vyayama FU 1.2 0.00 0.00 5.38 0.0031 S BT 2.4 0.60 0.17 AT 2.0 0.30 0.09 4.66 0.0055 S PEFR FU 1.9 0.42 0.13 7.67 0.0006 HS BT 23.0 3.42 1.10 AT 15.1 2.45 0.78 7.68 0.0006 HS Over all FU 12.1 1.70 0.53 11.19 0.0001 HS
Page 85
Results
Table No. 30 STATISTICAL ANALYSIS OF GROUP C RESULTS
Variable Grading on Mean SD SE t P value Significance
BT 2.8 0.62 0.21 AT 1.8 0.43 0.13 7.93 0.0005 HS Shwasakrichrata FU 1.8 0.40 0.13 5.94 0.0019 S BT 3.1 0.73 0.23 AT 1.7 0.39 0.12 4.32 0.0072 NS Ghurghuraka FU 1.8 0.45 0.14 4.18 0.0087 NS BT 2.5 1.12 0.35 AT 1.6 0.48 0.15 4.89 0.0043 S
Kasa FU 1.2 0.00 0.00 5.78 0.0023 S BT 2.7 0.86 0.27 AT 1.6 0.45 0.14 4.71 0.0088 NS Shwasakrichrata
(Duration) FU 1.7 0.41 0.13 4.43 0.0072 NS BT 2.4 1.11 0.35 AT 1.2 0.29 0.09 5.62 0.0025 S Nidra FU 1.2 0.00 0.00 5.38 0.0031 S BT 2.5 0.81 0.26 AT 1.3 0.39 0.12 8.18 0.0005 HS Prajna FU 1.1 0.00 0.00 9.23 0.0003 HS BT 2.1 0.64 0.20 AT 1.5 0.50 0.16 3.48 0.0183 NS Shwasakrichrata
(Speech) FU 1.3 0.40 0.13 6.39 0.0015 S BT 2.4 0.63 0.20 AT 1.7 0.48 0.15 7.68 0.0006 HS Vyayama FU 1.0 0.00 0.00 11.28 0.0001 HS BT 2.6 0.51 0.16 AT 1.8 0.42 0.13 7.63 0.0006 HS PEFR FU 1.7 0.41 0.13 7.63 0.0006 HS BT 22.4 2.39 0.76 AT 13.8 2.64 0.83 7.64 0.0006 HS Over all FU 12.1 1.69 0.53 9.21 0.0003 HS
Page 86
Results
Graph No. 21
0
1
2
3M
ean
valu
es
Mean scores of Shwasakrichrata in A, B & C groups
BTATFU
Group A Group B Group C
Graph No. 22
0
1
2
3
4
Mea
n va
lues
Mean scores of Ghurghuraka in A, B & C groups
BTATFU
Group A Group B Group C
Page 87
Results
Graph No. 23
00.5
11.5
22.5
3M
ean
valu
es
Mean scores of Kasa in A, B & C groups
BTATFU
Group A Group B Group C
Graph No. 24
0
1
2
3
Mea
n va
lues
Mean scores of Shwasakrichrata (Duration) in A, B & C groups
BTATFU
Group A Group B Group C
Page 88
Results
Graph No. 25
00.5
11.5
22.5
3M
ean
valu
es
Mean scores of Nidra in A, B & C groups
BTATFU
Group A Group B Group C
Graph No. 26
0
0.5
1
1.5
2
2.5
Mea
n va
lues
Mean scores of Prajna in A, B & C groups
BTATFU
Group A Group B Group C
Page 89
Results
Graph No. 27
0
1
2
3M
ean
valu
es
Mean scores of Shwasakrichrata (Speech) in A, B & C groups
BTATFU
Group A Group B Group C
Graph No. 28
00.5
11.5
22.5
3
Mea
n va
lues
Mean scores of Vyayama in A, B & C groups
BTATFU
Group A Group B Group C
Page 90
Results
Graph No. 29
00.5
11.5
22.5
3M
ean
valu
es
Mean scores of PEFR in A, B & C groups
BTATFU
Group A Group B Group C
Graph No. 30
0
5
10
15
20
25
Mea
n va
lues
Mean scores of Overall in A, B & C groups
BTATFU
Group A Group B Group C
Page 91
Results
OBSERVATION OF LABORATORY INVESTIGATIONS
All the groups have show similar effect on the individual laboratory investigation.
HEMOGLOBIN
Group C had shown a highest increase on Hemoglobin (3.05gms/dl), while group
A showed 2.15gms/dl increase and group B with an increase of 1.55gms/dl.
TOTAL LEUCOCYTE COUNT
Group C has shown highest reduction in TLC with 1420 cells/cc, group B with a
reduction of 1257 cells/cc and group A with a reduction of 760 cells/cc.
POLYMORPHS
Count in polymorph cells was increased in all groups with, 3.7% in group B
which was relatively greater than group C and group A with 3.4% and 3% respectively.
MONOCYTES
Group A and group B have shown no changes in the monocyte counts, where as
group C had shown a mild increase of 0.5%.
EOSINOPHILS
Group B had shown higher reduction in eosinophil count with 7% reduction
against 6.2% and 5.4% reduction in group C and group B respectively.
BASOPHILS
No change was observed in basophil count in any of the group.
ERYTHROCYTE SEDEMENTATION RATE
Group C had shown higher reduction in ESR with 16.7mm compared with
14.4mm and 13.4mm for group B and group A respectively.
ABSOLUTE EOSINOPHILIC COUNT
Group B higher influence on reduction of AEC i.e. 240 in comparison with 191
and 130 for group C and group A respectively.
Page 92
Results
SPUTUM EOSINOPHILS
Sputum eosinophils were greatly reduced in group B (6.1 HPF) in comparison
with (5.7 HPF and 5.1 HPF) respectively for group C and group A.
Table No. 31 OBSERVATIONS BASED ON LABORATORY FINDINGS
INVESTIGATION GROUP BT AT FU MEAN DIFFERENCE
A 9.65 9.65 11.8 2.15 (Increased) B 9.90 10.0 11.45 1.55 (Increased) HEMOGLOBIN C 10.0 10.55 13.05 3.05 (Increased) A 9574 9118 8814 760 (Decreased) B 9782 8800 8525 1257 (Decreased) TLC C 10820 10225 9400 1420 (Decreased) A 31.6 33.7 34.6 3.0 (Increased) B 31.3 33.8 35.0 3.7 (Increased) Polymorphs C 31.2 32.9 34.6 3.4 (Increased) A 5.6 5.6 5.6 0.0 B 5.6 5.6 5.6 0.0 Monocytes C 5.6 5.6 6.1 0.5 (Increased) A 53.1 54.2 55.5 2.4 (Increased) B 52.2 54.4 55.5 3.3 (Increased) Neutrophils C 52.4 53.7 55.7 3.3 (Increased) A 9.30 6.1 3.9 5.4 (Decreased) B 10.5 5.8 3.5 7.0 (Decreased) Eosinophils C 10.4 7.4 4.2 6.2 (Decreased) A 0.4 0.4 0.4 0.0 B 0.4 0.4 0.4 0.0 Basophils C 0.4 0.4 0.4 0.0 A 25.4 19.9 12.0 13.4 (Decreased) B 26.9 20.0 12.5 14.4 (Decreased) ESR C 26.2 18.0 9.5 16.7 (Decreased) A 490 416 358 132 (Decreased) B 515 450 275 240 (Decreased) AEC C 521 448 330 191 (Decreased) A 7.1 4.3 2.0 5.1 (Decreased) B 8.0 4.0 1.9 6.1 (Decreased) Sputum Eosinophils C 8.0 5.1 2.3 5.7 (Decreased)
Page 93
Discussion
Page 94
DISCUSSION
The ‘Tamaka shwasa’ caused by vata and Kapha doshas and dushya rasa dhatu is
the disorder of Pranavahasrotas. Pitta dosha if get involved in the pathogenesis lead to
pratamaka and santamaka shwasa. The detail description of Tamaka shwasa is available
in Brahatrayees and Laghutrayees.
Tamaka shwasa can be considered as bronchial asthma of modern science. In
Ayurvedic science more emphasizes is laid on the Shodhana Upakramas. In the treatment
of Tamaka shwasa more importance is given to Virechana i.e. Tamaketu Virecham: As
Virechana restores the normal flow of Vata, relieves the obstruction, normalise functions
of Pittasthana and expels the morbid humors Bharangyadi: kwatha on the other hand
possesses all the properties, which can expel the morbid Doshas, facilitating normal flow
of vata by relieving the obstruction. Considering long-term effect of Virechana and a
short duration management by Bharangyadi kwatha encouraged to undertake the present
study to clinically assess the efficacies of the either of therapies considering the classical
background.
NIDANA
Tamaka Shwasa is caused by wide range of etiological factors, in general from
dust, smoke, inherited factors. Even though it is difficult to establish a particular factor as
a causative factor for Tamaka shwasa.
As prevention is better than cure; classics have explained nidan parivarjana as a part of
preventive measures. It is important to understand the nidanas, which leads to the
Pathogenesis of the disease to prevent and also to provide appropriate treatment.
Some classics have explained nidanas of kasa and shwasa together, where as
some have explained hikka and shwasa nidanas together. It may to indicate the factors
affecting pranavaha srotas. Acharya chakrapani classified the nidanas into Vata
prakopaka and kapha prakopaka ganas. Nowhere in classics we get explanation of
Discussion
Page 95
pathological changes occurring due to causative factor. Hence to understand
Pathophysiology caused by ‘nidanas’ we can compare with modern science.
The Vataprakopaka and Kaphaprakopaka ganas explained by chakrapani can be
broadly considered as bronco constrictor and impaired secretary functions respectively.
Vataprakopaka Gana:
The functions of vata can be correlated with the neurological activities. And
Pranavata functions with the cranial nerve activities. The vagus nerve, which crosses the
thoraco abdominal limits reaches abdomen. It supplies to Pharynx trachea, heart stomach.
About pranavayu, sharangadhara has told ‘nabhista pranapavanaha’. Amashaya comes
almost towards space of naphi Any stimulation of epithelial vagal receptors, provokes
bronchoconstriction through both central and local reflexes. These factors leading to
bronchoconstriction may be included under Vataprakopaka Ganas.
Kaphaprakopaka Karanas:
¯¬dy°«d§Sd«dgŸŸSd«dd¦dy £dg ªdm¯d‰ ªd®de£d QgZešd£dZ | £d±Sdz®d Ÿd e®d«ddy´dd¦£dy «dgUgµ£dy‰ ¬dªd£dy ±dgšd«d Indicates excessive
secretion of the mucous thus Kaphaprakopaka lakshanas. In the modern science,
increased mucous secretion is because of the chemical mediators thus producing
pathophysilogy of the asthma. Hence the factors responsible for the release of mediators
can be considered as Kaphaprakopaka Ganas.
CONCEPT OF PITTASTHANA
I¶R¶®dd£dd£«dI¶®dy£ddz e§dÏd±¤dd¦d±d«dg×®ddz | Thus Charaka has described Tamaka shwasa as Pittasthana
samudbhava, but not clarified the role of Pittasthana in Pathogenesis. Chakrapani
described adho amashaya as pittasthana. It can be analised in three ways.
Discussion
Page 96
Biochemical View:
Histamine is responsible for the allergic & anaphylactic manifestations. It is
formed by decorboxylation of amino acid histidine and also synthesized by the micro
flora in the gastrointestine from dietary histidine. Concentration of histamine is rich in
stomach wall. It is present in biological fluids, in platelets, leucocytes, basophils and mast
cells. Histamine is present in animal lung. Histamine stimulates both H1 & H2 receptors
by acting on H1 receptors produces increased vascular permeability mucous secretion, by
acting on H2 receptors increases the gastric acid secretion.
Heamatological view:
The pitta sthana are said to be Sweda, rasa, lasika, rudhira and amashaya thus can
be considered as fluid tissues in the modern views. Chemical mediators Ex:- Histamine
Bradykinine leukotriens, when get increased in concentration in the blood produce an
inflammatory reaction involving bronchoconstriction, Vascular congestion and edema
formation.
Organic Concept:
Studies have revealed that increased gastric secretion, which tend to esophageal
reflux aggravate the asthmatic symptoms. In night, cardiac opening of stomach get
reduces its elasticity, thus gastric secretion regurgitates leading to sudden
bronchoconstriction due to irritation by regurgitated gastric contents which produces the
proximal nocturnal episodes which can be accounted for organopathological
consideration of adhoamashaya as pitta sthana.
INFECTION AND ALLERGY
Concept of Dushivisha can be correlated with the allergic manifestation
Madhavkara has included Shwasa in the list of disorder produced by Doshivisha. When
this visha remain in amashaya produces kapha vataja disorder. Thus we can consider
doshivisha as allergic factor.
Discussion
Page 97
Another view is graha rogas explained by Kashyapa, the infliction of bhutas are
invisible indicating towards the infective allergen or the invisible virus.
POORVARUPA
The poorva rupas for Shwasa are explained in the context of Hikka and Shwasa
and they are hritpeeda, anaha, adhmana, vaktravairasya and toda in shankapradesha.
Before the actual manifestation of the episode, due to narrowing of the air ways,
expiration become difficult and air gets trapped, which may be considered as anaha,
lateron the lungs gets over inflated, due to the trapped air and which may be considered
as Adhmana.
When the lungs are grossly distended, due to over stretching of the pleurae,
patient feels discomfort and uneasiness in the chest region, which may be considered as
Hritpeeda. In modern science it is already evident that histamine initiates episodes of BA.
Subcutaneous injection of the histamine produces severe throbbing headache and
temporal pulsation, which may be compared with Shanka Nistoda.
RUPA
Bronchial asthma is episodic in nature having asymptomatic phase in between. In
asymptomatic. Phase patient remain without symptoms. Hence the lakshanas explained
by classics are lakshanas during attack (Vegakaleena lakshanas).
Along with usually upper reparatory tract is involved that may be why peenasa is
also included in lakshana. Bronchial epithelium get dislodged because of inflammation
and increased mucous secretion in asthma. Because of these airway get partially
obstructed and produce wheezy sounds, when the air passes forcibly through narrowed
air ways. Acharya Charaka has explained kapha udeereana, srotoroda and ghurghur
shabdha. If obstruction is more person begins to respire forcefully, and suffers from
respiratory distress. Which Charaka has explained of ateeva teevravega shwasa and prana
Discussion
Page 98
prapedana. Patient of Tamaka shwasa, suffers from hypoxia when bronchial obstruction
is not relieved in spite of bouts of cough. Hence the lakshana “kasyata sanniruddhate
pramoham kasamanascha”. Patients feels more distressed due to failure to relieve
obstruction and feels relief for a short period when the sputum is expectorated, i.e. given
by Charaka sleshmanya muchyamane tu bhrisham bhavati dukhita tasyaiva cha
vimokshante muhurtam labhate sukham.
Patient feels too difficult to speak or difficulty in speaking due to respiratory
distress “krichana krichnoti bhashium”. Patient feel better in sitting position than lying
this is because, of diaphragm comes up reducing the space for expansion of lungs in lying
position. Thus the lakshana na chapi nidram labhate shayanasya swasaapeeditaha, aseeno
labhate soukhyam ushnam chivabhinandati.
Sweating dryness of mouth severe distress can be seen in reparatory failure & in
hypoxia are included by classics as lalata sweada, vishushkasya etc.,
SAMPRAPTI
The Samprapti should be understood thoroughly in order to treat or manage
Tamakaswasaa as it is very important to treat the disease. In Charaka samhitha we get
samanya samprapti of hikka and shwasa samanya samprapti for shwasa and specific
samprapti for Tamaka shwasa together will give clear idea regarding the pathogenesis of
the disease, sequential changes taking place in the pranavaha srotas leads to Tamaka
shwasa and in such condition if pitta gets associated it leads to the pratamaka or
santamaka shwasa, the avastha bhedas of Tamaka shwasa.
DISCUSSION ON CHIKITSA
Acharya Charaka has explained shodhana and shamana chikitsa according to
rogibalabala. That may be classified as treating acute condition and chronic condition.
Snehana, swedan and vaman help in the liquification and expulsion of kapha obstructing
Discussion
Page 99
the vata. Bahya snehan is advised may be in view that abhyantara snehana leads for
doshotkleshana. Sadhya vamana is advised for shwasa rogi suffering from jwara and
amadosha indicates management in emergency Nasya may helps in relieving congestion,
as peenasa is one of the lakshana and may act on respiratory center in the brain. Shamana,
bramhana indicate management of chronic conditions. Doshanusar chikitsa seems to be
avarana chikitsa.( supported chikitsa of kaphavrita pranavata).
‘Tamaketu Virechanama‘ told by Charaka seems interesting as there is no direct
reference regarding involvement of pitta except pratamaka santamaka avastha.
We can put hypothesis of virchana having adhobhagahar karma & vatanulomana
karma. thus relieving obstruction of vata by kapha. In bronchial asthama parasymphetic
hyperactivates, probably Virechana by its prabhava suppress the parasymphathetic
activities and stimulate the symphathetic.
Virechana is indicated pittasthanagata kapha for expelling vikrita kapha.
Pittasthanagata kapha can be compared with gastro intestinal secretion concentrated with
histamine which should be eliminated. Micro flora in the gut which synthesize histamine
may be inactivated by the Virechana & these mediators are circulating in the body
initiates episodes of bronchial asthma. Virechana being is a shodhana upakrama for pitta
thus acting as raktha shodhaka hence removes the circulating mediators.
MATERIAL & METHODS
Materials:
Shunti phanta: It is used for amapachana and agnideepana. Shunti is uttama amapachaka
vata kaphara and nati pittakara, swarya hridya. Phanta was preferred as it is easy for the
preparation.
Lavana taila: Lavana is aruksha, sookshma, ushna and vyavaya helps in snehana when
mixed with sneha dravyas. The tila taila is vatahara. Lavana taila was taken for bahya
snehana for dosha vilayana.
Discussion
Page 100
Nadi sweda: Nadi sweda was preferred as it easy procedure & was done with, vatahara
dravyas having ushna veerya.
Erand taila: Acharya Charaka explained Erand taila as uttama in snigda Virechana. It
is katu, snigdha, vatakaphahara. In patient where snehapana is not given or sarvanga
abhyanga is not done there acharya Charaka indicated snigdha Virechana. In Tamaka
shwasa sthanica snehana with lavana taila is mentioned as doshotkleshana is not
indicated.
Bharangyadi kwatha: Which is indicated for Tamaka shwasa by Yogaratnakara and
Bhaishajya ratnavali contains Bharangi, Shunti both are kaphavatahara, pachana,
Bharangi is shotaghna act on pathology of Tamaka shwasa hence proved
uttamashamanadravya.
Methods:
Aim:
“A clinical study on the management of Tamaka shwasa with special reference to
Tamaka shwasa”. The aim of the study was took clinically assesses the efficacy of the
Virechana and Bharangyadi kwatha as the classical statement regarding the undertaken
therapies seems quit encouraging toward management for TS.
Plan of study:
In the present study, a total of 36 patients suffering from Tamaka shwasa where
taken from OPD and IPD of ALN Rao Ayurveda & Hospital, out of 36 patients, 6
patients discontinued the study because of non medical reason. The signs and symptoms
of Tamaka shwasa, among those 3 major symptoms are considered as diagnostic purpose
swasakrichrata, Ghurguraka kasa
PEFR:
PEFR values varies from age, sex, height, weight. In normal persons also dirunal
variation in PEFR values is observed & also on different days with relation to nature of
Discussion
Page 101
stress and strain. Hence a resting PEFR was recorded when patient seems to be normal
and was considered as base line reading for that particular individual at least 15% dirunal
variation from the base line value was considered as diagnostic. A pre determined
randomized sampling method was adapted patients are categorized into 3 groups each
group contain of 10 patients. The technique was adapted in order to avoid the sampling
bias.
Intervention:
A pilot study on 6 patients was done, in order to grade the severity for individual
symptom & overall severity, dose fixation, determine end point & grading for the
assignment of clinical improvement.
Group A:
All the patients were having varied degree of Sama lakshanas hence shunti phanta
between 20-40ml was given to all twice daily till nirama lakshanas observed. Snehana &
Swedana was performed on the next day after nirama lakshanas 15-45ml of Eranda taila
was given for the Virechana. The dose was decided on the basis of kostha. 15ml for
mridu, 30ml for madhyama and 45ml for krura kostha. Antiki & laingiki shuddhi where
considered as the end point of Virechana and considered as samyak virikta. Samsarjana
krama was advised after Virechana. After samsarjana krama all the patients visited OPD
weekly for a regular follow up for 1 month.
Group B:
Bharangyadi kwatha 15-20ml twice daily for a week was administered to the
patients in this group. All patients were advised to visit the OPD weekly for a regular
follow up for 1 month.
Group C:
After completion of intervention similar to Group a, each patient was provided
with the medicine in the order as of group b. All the patients received the medicine in the
Discussion
Page 102
proper manner for all the 1 week. All the patients visited OPD weekly for a regular
follow up for 1 month.
GENERAL DESCRIPTION OF PATIENTS
In the present sample taken for the study the patients belonged to the age group
15-65 years maximum number of patients belonged to the age group of 20-30 years.
Bronchial asthma occurs at all ages but predominantly found from the very start of early
childhood (below 10 years). This tendency is not seen in this sample, as the patients
below the age 15 years were not taken for the study. In this study male and female patient
ratio was 3:2. Earlier studies tells about the sex ratio i.e. in the childhood there is 2:1
male/female preponderance but sex ratio equalizes by the age (E.R. Mc Fadden Jr) in the
present study no cases were registered below the age 15.
About prakruti, there is no any direct reference regarding the particular prakruti
person getting affected more by Tamaka shwasa but with the observation in the present
study it can be presumed that vatakaphaj prakruti persons gets affected more by Tamaka
shwasa compared to other prakruti persons i.e. 46.66% of the vatakaphaj prakruti persons
gets affected by Tamaka shwasa. Hence it can be said that vatakaphaj prakruti persons
are more prone towards Tamaka shwasa.
In present sample of 56.66% patients were having mandagni, no one patients was
with samagni by which it can be inferred that mandagni acts as an exciting factor for the
episodes of Tamaka shwasa.
Acharya Charaka has mentioned hat when disease become chronic, it leads to
dhatu kshaya. It is reflected in this study that rogibala declines gradually with progression
of the disease or its chronicity.
Patients were almost equally distributed in rural & urban area (46.67%, 53.33%),
hence in present study, no significance regarding habitat was observed, in comparison
Discussion
Page 103
with environmental difference between rural and urban areas as the hospital, is in urban
area surrounded by many villages.
In this study most of the patients were students contributing about 36.66% and
20% housewives rests were distributed widely in other occupations. A large sample may
be required to reveal and support the previous studies.
All the patients were educated, at least to understand the instruction correctly and
also that every one followed the instruction properly 67% patients showed positive
response for variation of the disease status with relation to food stuffs, 33% showed no
response to food, which suggest food stuff were exciting factors. Acharya Charakadhi
have described influence of ahara in nidana and pathyadi is justified here.
In this study patients having influence of climatic changes on the disease attacks
were 53.33% and not having influence were 46.67% thus it supports the role of climate.
Majority of patients in this study were non-smokers (66.66%) 33.33% incidents of
smoker to get affected by Tamaka Shwasa indicating smoking is non-specific nidana for
Tamaka shwasa.
Only 30% patients were tobacco chewers, 70% were non tobacco chewers and
26.67% patients were alcohol consumers and 73.33% were non-consumer hence showing
tobacco and alcohol are not having significant role in Tamaka shwasa. 66.66% patients of
Tamaka shwasa were also having pratishyaya (allergic rhinitis) which support pervious
studies.
INTERVENTIONS BASED OBSERVATIONS
Group A and C:
Involvement of pitta sthana and also the annavaha srotas is supported by study as
all the patients were presented with samalaxana. Shunti phant given for agni deepagna,
amapachana was palatable. It was given 20-40%ml for the patients of group A and group
C. Considering the patients tolerance 40ml of shunti phanta can be fixed within 2 days
Discussion
Page 104
50% of patients attainted niramavastha with a mean of 2.5 days. Hence the minimum of 3
days is needed in order to attain niramavastha in majority of patients.
To attain samyak shuddhi lakshanas of Virechana quantity of Eranda taila
required was 15-45ml for group A and group C. In this study varied number of Vegas 8-
22 were observed indicating alpa, madhyama doshavastha. On an average of 15-16 Vegas
are essential to attain the shuddhi lakshanas. Study has supported the importance of antiki
and laingiki shuddhi lakshanas.
After the administration of Eranda taila for the on set of Vegas on an average of
110min were required. Eranda taila acts on intestines is evident by increased peristalsis.
The stool was semisolid for initial few Vegas then become watery at the end was
associated with mucous like substance thus we can include Eranda taila in Rechaka
group. In the first hour on an average of 9 Vages were observed depending upon the
degree of shodhana samsarajan krama (3-5 days) was advised. On an average 9 days were
required for the completion of Virechana chikista in both group A & group C and in
group c after 9 days patients were advised to take Bharangyadi kwatha 15-20ml twice
daily for 1 week.
Group B:
In this group also all patients were having samalakshanas as Bharangyadi kwatha
itself is having Shunti as well as Bharangi both does the pachana instead of giving Shunti
phata Bharangyadi kwatha was directly given. Bharangyadi kwatha 15-20ml twice daily
was given for 1 week.
ASSESSMENT OF VARIABLES
During the pilot study which was done on 6 patients, where in the presentation
from each patients was collected against each variable. With the help of textual
references slight modification were done and variables were graded as Prakritha ‘1’,
Discussion
Page 105
Mridu ‘2’, Madhyama ‘3’ and teevra ‘4’. Grading for all the variable and mode of
grading are presented along clinical proforma, formulated for present study.
For present study 9 variables were taken overall severity is based on the total
values of 9 variable and was graded as
Prakrita - 0-9
Mridu - 10-18.
Madhyama - 19-27
Teevra - 28-36
Clinical improvement:
Was assessed using the severity grades. It is graded as follows
CD: -clinically deteriorated, i.e. increase in severity score against the initial score.
CS: -clinically stable i.e. severity remains as against the initial score.
CI-1: -Encouraging i.e, one degree reduction in the severity score against the initial
score this means reductions. From, mild - normal, moderate - mild and severe -
moderate.
CI-2: -good i,e. 2 degree reduction in the severity score against the initial score. This
means reduction from, moderate-normal severe mild.
CI-3:-Excellent, 3 degree reduction in the severity score against the initial score this
means reduction from severe-normal.
Overall severity of the disease was also graded in similar manner and was as,
CD: -clinically deteriorated, i,e. increase in severity score against the initial score.
CS: -clinically stable i.e. severity remains as against the initial score.
CI-1: -Encouraging i.e. reduction of 9 degree from initial score.
CI-2: -good i.e. reduction of 18 degree from initial score.
CI-3:-Excellent, i.e. reduction of 27 degree from the initial score.
Discussion
Page 106
TREATMENT DURATION
Group A:
Virechana was given to this group of patient and duration was 9 days and is
including samsarjana krama. .
Group B:
Bharangyadi kwatha was given for 1 week.
Group C:
Virechana and Bharangyadi kwatha was given to this group of patients and
duration was 16 days. (for Virechana 9 days and for Bharangyadi kwatha 1 week).
DURATION OF FOLLOW UP
One moth of duration was taken for follow up, as the patients with at least one
attack per week were selected. Hence the effect can be assessed in the course of one
month. In case of encouraging results a long term study can be recommended as this
disease has the variable duration of remission period from days to few years.
COLLECTION OF DATA AND STATISTICAL ANALYSIS
Data was collected before treatment, after treatment and every weekend during
follow up and at the end of follow up. This is properly documented for statistical
analysis. Data collected before treatment, after treatment and at the end of the follow up
were considered the data collected were statistically analysed under the guidance of
statistician.
DISCUSSION ON RESULTS
Swasakrichrita :
The mean score of swasakrichrata in group A reduced from 2.6 to 2.1 at the end
of treatment this result was statistically significant at end of treatment where as for group
B mean score reduced from 2.8 to 1.7, showing result as highly significant at the end of
treatment. Result of group C was highly significant at the end of treatment.
Discussion
Page 107
At the end of follow up result in group A was nonsignificant, while group B was
highly significant in group C it was reduced from highly significance to significance.
Hence it can be said that alone Bharangyadi kwatha has highly significant effect
on swasakrichrita over the whole course of management.
Ghurguraka:
Group A had highly significant result at the end of treatment (P<0.001)
Was reduced to significant at the end of follow up, mean score of ghurguraka in group B
reduced from 2.9 to 2.0 at the end of treatment thus effect was significant and it increased
to higher significance at the end of follow up. In case of group C effect was non
significant at the end of treatment till the end of follow up. Hence, Virechana alone has
good result on ghurguraka after the treatment and later course its effect was reduced,
while Bharangyadi kwatha has improved effect during the follow up and end of the
follow up.
Kasa:
Mean score of Kasa in group A reduced from 2.7 to 1.7 at the end of treatment
thus showing significancy and at the end of follow up mean score was 1.3 significance
thus reduced to nonsignificance (P<0.001).
Mean score of group B reduced from 2.6 to 1.6 and 1.1 at the end of treatment and
follow up respectively thus remained highly significant through out observation. Group C
shown significant result both at the end of treatment as well as end of the follow up.
Duration of Swasakrichrita:
Group A shows significant result at the end of treatment was reduced to non
significant. Group B result remained highly significant at the end of treatment and at the
end of follow up Group C result remained non significant.
Discussion
Page 108
PEFR:
In group A, P value was <0.001 at both the end of treatment and follow up,
Virechana was highly significant effect on PEFR value. Bharangyadi kwatha had
significant effect on PEFR after treatment and effect was improved highly significant at
the end of the follow up. Group C had a highly significant effect on PEFR after treatment
and at the end of follow up.
Nidra:
Group A, mean score reduced from 2.8 to 1.8 P value >0.001. Hence Virechana
was non significant after treatment and at the end of follow up. While Bharangyadi
kwatha had significant effect on Nidra after treatment and at the end of follow up. Group
C results were similar to that of group B.
Prajna:
Effect of Virechana was non significant on Prajna after treatment and had a highly
significant improvement at the end of follow up, while Bharangyadi Kwatha had a
significant effect on Prajna after treatment and end of follow up. In group C, Virechana
and Bharangyadi kwatha together had a highly significant effect on Prajna after treatment
and at the end of follow up.
Swasakrichrita on speech:
Mean score of Swasakrichrita in group A reduced from 2.7 to 1.6 at the end of
treatment thus Virechana had highly significant on Swasakrichrita on speech. Group B
i.e. Bharangyadi kwatha had significant at the end of treatment improved to highly
significant at the end of follow up. In group C result was non significant at the end of
treatment improved to significant at the end of follow up.
Vyayama:
Virechana had highly significant effect on Vyayama after treatment and the effect
was reduced to significant at the end of the follow up. While Bharangyadi kwatha had a
Discussion
Page 109
stable significant effect on Vyayama after treatment and at the end of follow up. Group C
had highly significant effect on Vyayama after treatment and at the end of the follow up.
Overall:
Effect of Virechana on overall severity was non significant, where as Bharangyadi
kwatha has highly significant effect after treatment and highly significant at the end of
the follow up. Group C had highly significant effect after treatment and at the end of the
follow up on the overall severity of the disease.
Hence Virechana alone is not having significant efficacy to clear the air way
obstruction. Which is evident by the effect of Virechana on Swasakrichrita Kasa and
ghurguraka; but it had a highly significant effect on the Swasakrichrita on speech,
vyayama and PEFR, which indicates that Virechana helps in increasing the vital capacity
of the lungs and effort based activity. Bharangyadi kwatha is more effective in relieving
on Swasakrichrita, Kasa, ghurguraka, and also had a significant effect on effort based
activities. Virechana followed by Bharangyadi kwatha on an overall had highly
significant effect.
Acharya Charaka has mentioned, Shamana therapy, which is absolutely free from
the adverse effects, should be preferred for the treatment of shwasa. This is supported by
the present study.
DISCUSSION ON LABORATORY INVESTIGATIONS
Mean score for hemoglobin in group A increased from 9.65 to 11.8 at the end of
follow up and in group B increased from 9.90 to the 11.45. Thus reveals that Virechana
being pittashodhaka acts on raktadhatu as a shonita sthapaka, Rakta shodhaka, better than
Bharangyadi kwatha. In group C increased from 10.0 to 13.05, combined effect of
Virechana and Bharangyadi kwatha can be seen in this group.
Discussion
Page 110
Mean difference of TLC in the group A was 760 (decreased) and in group B, 1257
and group C, 1420. Thus Bharangyadi kwatha have significant effect on the reduction of
TLC.
Both Bharangyadi kwatha and Virechana have increased polymorphs, neutrophils,
whereas they have no specific effect on monocytes and basophils, as the count remain
unchanged. Esinophil count have been significantly reduced both by Virechana and
Bharangyadi kwatha.
Mean score for ESR in group A reduced from 25.4 to 12.0, in group B it is
reduced from 26.9 to 12.5 and it was reduced from 26.2 to 9.5 in group C. Thus revealing
that, both Virechana and Bharangyadi kwatha have significantly reduced the ESR, more
reduction was seen in group A and group C thus once again revealing the action of
Virechana on raktadhatu.
Mean difference of sputum Esinophils in three groups was 5.1, 6.1 and 5.7 (all
decreased). Hence both Virechana Bharangyadi kwatha have reduced the sputum
Esinophils, more effect was observed by Bharangyadi kwatha.
Conclusion
CONCLUSION
The disease Tamaka shwasa though it is yapya by its nature it is Sadhya when it is
new onset in patient having enough strength. When disease becomes yapya, we can try at
least to reduce its severity.
A close perusal of the observations the following conclusions can be drawn.
• For the disease Tamaka shwasa which is episodic in nature, no specific etiology can
be established.
• Tamaka shwasa affects invariably patients of any age with more incidences in the age
20-30.
• One of the exciting factor may be mandagni.
• Strength of the patient decreases with the chronicity of the disease.
• Virechana proved its efficacy in enhancing the vital capacity of lungs as well as effort
based activities
• Virechana showed little effect over the airway obstruction
• Bharangyadi kwatha is more effective in relieving over the airway obstruction as well
as it has a significant effect on effort based activities.
• Virechana followed by Bharangyadi kwatha on an overall has highly significant
effect.
• From this study we can conclude that Virechana acts as Vatanulomaka,
Shonitasthapaka and Raktashodhak.
• Both Bharangyadi kwatha and virechana both showed greater significance in reducing
E.S.R and overall remarkable effect on hematological values
Page 111
Conclusion
Limitations:
• The size of sample was small to draw a generalized conclusion.
Recommendation for the future study:
• The study is advised in large sample for longer duration.
• Role of virechana as well as Bharangyadi kwath on CD4 count.
• Role of frequent virechana in the prevention of the onset of episodes.
Page 112
Summary
Page 113
SUMMARY
“A clinical study on the management of Tamaka shwasa with special reference to
virechana and Shamana” has been carried out to find out the efficacies of either of
therapies on patients of Tamaka shwasa. This study contains Introduction, Objectives,
Review of literature, Methodology, Results, Discussion and Conclusion.
Chapter I objectives of study are explained.
Chapter II under Review of literature detail description about Tamaka shwasa
according to Charaka Samhita, Sushruta Samhita, Astanga Hridaya and Madava nidana
etc. are compiled. The description of Bronchial asthma according to modern science is
also complied. Concept of Virechana according to different authors is also explained.
Brief description about drugs Bharangi, Shunti, used in Bharangyadi kwatha and Eranda
which is content of Eranda taila was also included under review of literature.
Chapter III methodology – material and methods includes collection of drug,
instrument, method of using the instrument. Grading for the disease and grouping of
patient etc. are explained.
Chapter IV Results – general observation of patients, distribution of patients,
according to age, sex, economical status, education, habitat, food etc. is represented along
with pie charts. Results of the therapies after end of the treatment, end of the follow up
along the statistical analysis is mentioned.
Chapter V Discussion - includes elaborated discussion about disease, chikitsa,
and results of therapies.
Chapter VI Conclusion – here it is concluded that Virechana alone is not having
significant effect to clear the air way obstruction but it has a highly significant effect in
improving the vital capacity of lungs. Virechana mainly acts as pittashodaka thus
raktashodaka. Bharangyadi kwatha more effective in relieving the air way obstruction
also has significant effect on effort based activities. Virechana followed by Bharangyadi
kwatha on an overall has a highly significant effect.
REFERENCES
1. Sha .Sa.P.K.5/47-50.
2. C.Sa.Chi.17/17.
3. C.Sa.Chi.17/60.
4. C.Sa.Chi. 17/121
5. A. San.Su 27/5.
6. Y.R.Swa.Chi.39
7. B.R.16/23
8. Madhukosha - Ibid.
9. Su.Sa.U 51/1
10. Cha. Sa.Chi.17/13
11. A.H.Ni.4/1
12. Cha.Sa.Chi. 17/11-16
13. Su.Sa.U.51/3
14. A.Sa.Ni.4/2-3.
15. A.H.Ni.4/1.
16. B.P 14/1
17. Y.R.Swa.Chi.1
18. Ma.Ni.12/1-2
19. Cha.Sa.Chi. 23/31.
20. Su.Sa.K.2/28
21. Ma.Ni.69/31.
22. A.San.Ni.4/12.
23. Cha.Sa.Chi. 17/10-13.
24. Cha.Sa.Chi. 17/62.
25. Cha.Sa.Chi. 17/55
26. Cha.Sa.Chi. 17/56
27. Cha.Sa.Ni.1/11.
28. Chakrapani – Ibid (Cha.Sa.Chi
17/63-64)
29. Cha.Sa.Chi.17/8.
30. Ma.Ni 12/15
31. Cha.Sa.Chi.17/148.
32. Cha.Sa.Chi.17/68.
33. Cha.Sa.Chi. 17/62.
34. Su.Sa.U.51/13.
35. Cha.Sa.Chi.17/62.
36. Ma.Ni.1/5-6
37. Cha.Sa.Chi.17/20.
38. Su.Sa.U.51/6.
39. A.San.Ni.4/6.
40. A.H.Ni.4/4.
41. B.P.14/3
42. Y.R.Swa.Chi.6
43. Ma.Ni.12/17.
44. Cha.Sa.Chi.17/56-62.
45. Su.Sa.U.51/8-10
46. A.San.Ni.4/8-12.
47. A.H.Ni.4/6-10.
48. B.P.14/14-21
49. Y.R..Swa.Chi.16-23
50. Ma.Ni.12/27-34.
51. Cha.Sa.Chi.17/63.
52. Cha.Sa.Chi.17/64.
53. Cha.Sa.Chi.17/56.
54. Cha.Sa.Chi.17/58
55. Cha.Sa.Chi.17/61.
56. Cha.Sa.Chi.17/60.
57. Cha.Sa.Chi.17/60.
58. Madhukosha –Ibid (Ma.Ni.1/8).
59. Cha.Sa.Chi.17/58
60. Cha.Sa.Chi.17/60.
61. Cha.Sa.Chi.17/60.
62. A.H.Ni.1/7.
63. Cha.Sa.Chi.17/62.
64. Cha.Sa.Chi.17/59.
65. Cha.Sa.Ind. 7/24.
66. Cha.Sa.Ind. 7/25.
67. Cha.Sa.Ind.7/26.
68. Cha.Sa.Ind.8/15
69. Cha.Sa.Chi.17/62.
70. Su.Sa.U.51/13.
71. A.H.Ni.4/18.
72. Cha.Sa.Chi.17/147-150.
73. Cha.Sa.Chi.17/149.
74. Su.Sa.U.1/25.
75. Cha.Sa.Chi.17/82.
76. Cha.Sa.Chi.17/89.
77. Cha.Sa.Chi.17/77.
78. Cha.Sa.Chi.17/90.
79. Cha.Sa.Chi.17/91.
80. A.San.Su.27/5.
81. Cha.Sa.Chi.17/112.
82. Cha.Sa.Chi.17/113.
83. Cha.Sa.Chi.17/114.
84. Cha.Sa.Chi.17/117.
85. Cha.Sa.Chi.17/121.
86. Su.Sa.U.51/30.
87. Cha.Sa.Chi.17/139.
88. Cha.Sa.Chi.17/149.
89. Cha.Sa.Chi.17/149.
90. Cha.Sa.Chi.17/100.
91. Su.Sa.U.52/46-47.
92. A.H.Ni.4/54.
93. Y.R. Swa.Chi.1-4.
94. B.R.16/134.
95. Cha.Sa.Ka.1/4.
96. Cha.Sa.Su.25/40.
97. A.H.Su.13/1.
98. A.S.Su.27/5.
99. Cha.Sa.Su.25/40.
100. Cha.Sa.Chi.6/9.
101. Sha.Sa.P.K.4/3-6.
102. Cha.Sa.Su.1/77-80.
103. Cha.Sa.Su.1/81-85.
104. Cha.Sa.Su.1/114-115.
105. Su.Sa.Su.44/1-2.
106. Su.Sa.Su.44/1-2.
107. Su.Sa.Su.44/1-2.
108. Cha.Sa.Su.1/89.
109. Cha.Sa.Su.15/17.
110. Sha.Sa.U.K.4/16-17.
111. Cha.Sa.Si. 1/18.
112. Su.Sa.Chi.33/23.
113. Cha.Sa.Si.1/17.
114. Cha.Sa.Si.9/12.
A.H.Su.18/30.
115. Cha.Sa.Si.1/11.
A.H.Su.18/129.
116. Cha.Sa.Si.12/10-11.
117. Cha.Sa.Chi.17/121.
118. Su.Sa.Su.45/112.
119. Cha.Sa.Su.27/301.
120. Su.Sa.Su.45/114.
121. Cha.Sa.Chi.17/109-110.
122. Su.Sa.U.51/44.
123. A.H.Chi.4/32.
124. B.P.M.K.14/34.
125. Y.R. Swa.Chi.39.
126. B.R.16/23.
127. Iatro.Che.Ayu. 146-147.
128. Ha.Sa.3/1.
129. A.P. of India Part –I Vol III.
130. A.P. of India Part –I Vol III.
131. A.P. of India Part –I Vol III.
132. B.P.Ni.H.V
133. B.P.Ni.H.V
134. B.P.Ni.G.V
BIBLIOGRAPHY
1) Sharangdharacharya, Saharangdhara Samhita, edited by Prof.K.R.Shrikanta Murthy,
published by Chaukhambha Orentalia, Varanasi, 3rd edition, 1997.[Page No.25]
2) Agnivesha, Charaka Samhita vol II, edited by Pandit Kashinath Shastri and Dr
Goraknath Chaturvedi, published by Chowkhamba Vidyabhavan, Varanasi, 2nd
edition, 1970, [Page No.508-531]
3) Vagbhata Astanga Sangraha Edited by Kaviraj Athrideva Gupta, Published by
Krishnadas Academy, Varanasi, 1st Edition Reprinted 1993. [Page No.197]
4) Shri Laxmipati Shastri , Yogaratnakara, edited by Brahmashankara shastri, published
by Chaukhambha Sanskrit sansthana, Varanasi, 7th edition, 1999, [Page No.427-436].
5) Bhishagaratna nshri Bharmhashankarmishra Bhaishajya Ratnavali edited by Kaviraj
shri Ambikadatta Shastri published by Chowkhambha Sanskrit series office, Varanasi
16th edition 2002 (Page No 332).
6) Madhavakara, Madhavanidanam, edited by Sudarshanashastri yadunandanopdhaya,
published by Chaukhambha Sanskrit sansthana, Varanasi, 23rd edition, 1994, [Page
No. 281-301].
7) Sushruta, Sushruta Samhita Uttaratantra, edited by Ambikadatta Shastri, published by
Chowkhambha Sanskrit series office, Varanasi, 3rd edition, 1976, [Page No. 372-382].
8) Vagbhatta, Astanga Hridaya, edited by, Harishastri Paradkar Vaidya, published by
Krishnadas Academy, Varanasi, 1st edition, 2000, [Page No.472-476, 602-609].
9) Bhavamishra, Bhavaprakasha Samhita, edited by Bramhashankar Mishra, published
by Chaukhambha Sanskrit sansthana, Varanasi, 7th edition, 2000, [Page No. 159-166].
10) Chakrpanidatta, Ayurveda Deepika, edited by Vaidya Jadavaji Trikamji Acharya,
puyblished by Chaukhambha Sanskrit sansthana, Varanasi, 5th edition, 2001, [Page
No. 533-539].
11) Chakradatta, Chakradatta, edited by Privratta Sharma, Chaukhambha Orentalia,
Varanasi, 1994, [Page No.145-149].
12) Arunadatta, Sarvanga Sundara, edited by Harishastri Paradkar Vaidya, published by
Krishnadas Academy, Varanasi, 1st edition, 2000, [Page No.472-476, 602-609].
13) Dalhana, Nibandha Sangraha Vyakhya, Narayan Ram Acharya, Chaukhambha
Orientalia, Varanasi, 7th edition, 2002, [Page No.761-765].
14) Haridas. S. Kasture, Ayurvediya Panchakarma Vijnana, edited by Haridas. S.
Kasture, published by Baidynath Ayurveda Bhavan, Nagapur, 4th edition, 1993, [Page
No. 307-383].
15) Hemadri, Ayurveda Rasayana, edited by Harishastri Paradkar Vaidya, published by
Krishnadas Academy, Varanasi, 1st edition, 2000, [Page No.472-476, 602-609].
16) Kashirams, Gudarthadeepika, edited by parusharama Shastri Vidyasagar, published
by Chaukhambha Orentalia, Varanasi, 4th edition, 2000.
17) Prof R. H. Singh, Panchakarma Therapy, edited by Prof R. H. Singh, Chaukhambha
Sanskrit Series, Varanasi, 1st edition, 1992, [Page No.64-75].
18) Sri Gangadhar, Jalpakalpataru, edited by Kaviraj Shree Narendranath Sengupta,
published by Chaukhambha Orentalia, Varanasi, 1st edition, 1991, [Page No.3001-
3032].
19) The Ayurvedic Pharmacopoeia of India, published by Government of India, ministry
of health and family welfare, Department of health.
20) Arthur.C.Guyton and John.E.Hall, Text book of Medical Physiology, edited by
Arthur.C.Guyton and John.E.Hall, published by Prism Books Pvt. Ltd, Bangalore, 9th
edition, 1996, [Page No.477-561].
21) Catron, Kumar, Collins et.al. Robbins Pathological Basis of diseases, edited by
Catron, 6th edition, [Page No.711-716].
22) Chandi Charan Chatterjee, Human Physiology Vol-I, edited by Chandi Charan
Chattergi, published by A. K. Chatterjee, Calcutta, 11th edition, 1992, [Page No.365-
426].
23) Dr A. C. Tripathi, Differential Diagnosis, a manual of common complaints, edited by
Dr. A. C. Tripathi, published by Paras Medical Publisher, Hyderabad , 1st edition,
1997, [Page No.331-372].
24) Dr Mark Levy, Asthma at your finger tips, edited by Dr Mark Levy, published by B.
Jain publishers, New Delhi.
25) Dr O. P. Jaggi, Asthma and Allergies, causes prevention and treatment, edited by Dr
O. P. Jaggi, published by Orient Paperbacks, Delhi, 2nd edition, 9th printing, 1999.
26) Dr Paul. J. Hannaway, The Asthma Self-help Book, edited by Dr Paul. J. Hannaway,
published by Orient Paperbacks, 1st edition second printing, 1996.
27) Harison, Harison Principles of Internal Medicine vol II, edited by Anthony
Significant Fauci, Grow hill health professions division, New Delhi, 14th edition,
2002, [Page No.1456-1463].
28) Harsha Mohan, Text Book of Pathology, edited by Harsha Mohan, published by
Jaypee Brothers Medical Publishers (P) Ltd. New Delhi 110002, India, 2nd edition,
1995, [Page No. 465-467].
29) Henrey Gray, Gray’s Anatomy, edited by Peter.L.Williams and Roges Warwic,
published by Churchill Livingstone, Edinburgh London, 37th edition, 1989, [Page
No.1248-1286].
30) J.S.Guleria, API Text book of Medicine, edited by Gurmukh.S.Saini, published by
Association of Physicians of India, Bombay, 5th edition, 1997, [Page No.286-290].
31) John Macleod, Christopher Edwards, Davidson’s Principle and Practice of Medicine,
edited by Christopher Edwards, published by Churchill Livingstone, U.K. ltd, 15th
edition, 1990, [Page No.243-240].
32) K. Sembulingam, Prema Sembulingam, Essentials of Medical Physiology, edited by
K and Prema Sembulingam, published by Jaypee Brothers Medical Publishers (P)
Ltd. New Delhi, India, 2nd edition, 2002, [Page No.517-579].
33) K.D.Tripathi, Essentials of Medical Pharmacology, edited by K.D.trapathi, published
by Jaypee Brothers Medical Publishers (P) Ltd. New Delhi, India, 4th edition, 1999,
[Page No.226-238].
34) K.Park, Text book of preventive and social medicine, edited by K.Park, published by
M/S banarsidas Bhanot, Jabalpur (India), 16th edition, 2000, [Page No.131-137 and
504-510].
35) Mary.F.Lipscomb, Basic Pathology (Indian edition), edited by Vinay Kumar, Prism
Books Pvt. Ltd, Bangalore, 5th edition, 1992, [Page No.389-391].
36) Michael Swash, Hutchison’s Clinical Methods, edited by Michael Swash, published
by Bailliere Tindall, 19th edition, 1993, [Page No.186-217].
37) O. P. Ghai, Essential Pediatrics, edited by O. P. Ghai, Interprint publishers, New
Delhi-, 4th edition, 1996, [Page No.285-289].
38) R. S. Satoskar and S. D. Bhandarkar, Pharmacology and Pharmacotherapeutics, vol I,
edited by R. S. Satoskar and S. D. Bhandarkar, published by popular prakashan pvt.
Ltd. Bombay, 10th edition, 1986, [Page No. 269-278, 292-299].
39) Ramnik Sood, Medical Laboratory technology, methods and interpretations, edited by
Ramnik Sood, published by Jaypee Brothers, New Delhi, 4th edition, 1994.
40) Rustom Jal Vakil, Physical Diagnosis A Text book of symptoms and signs, edited by
Rustom Jal Vakil, 8th edition, 1999, [Page No.336-394].
CLINICAL PROFORMA FOR THE STUDY ON TAMAKA SVASA
Name: Date: Case No: Age/Sex: Caste: Education: Occupation: Socio-Economical Status: OPD no: Address: IPD no: Group:
PRADHANA VEDANA: Svasa Krichrata, Kasa, Kapha Stheevana, Pratishya, Nasanaha, Urashula, Kanthakandu, Shirashula, Dhur Dhur Dwhani, Jwara, Bhrama, Murcha. DURATION: . . Days/Weeks/Months/Years. ANUBANDHI VEDANA: ADYATANA VYADHI VRATTANTA: SVASA: MODE OF ONSET & COURSE
Shigrotpatti Chirotpatti.
Ashukari Chirakalasthi.
Nirantara Saantara Savegan.
Prograssive Exacerbations and Remissions.
Nocturnal Episodes Induced By Aspiration of Food.
Oropharyngial Contents Foreign Body.
Precipitated By Aahara, Vihara, Raja, Dhuma, Others.
Attacks, Once/ Twice/ Frequently Per; Day/ Week/ Month/ Year.
Individual Attacks Last In Response to Treatment.
Type of Treatment.
CHARACTER
Krichra Prana Vilomata (Laboured Expiration).
Sudheerga Sashabdha Svasa (Loud Prolonged Expiration).
Sudheerga Urdhva Svasa, Nisvasa Rahita (Prolonged Expiration with,
No or Little Inspiration).
Sudheerga Urdhva Svasa Nisvasa Youktha
(Prolonged Expiration Followed, by Inspiration).
Pause in Between Respiratory Phases.
Sense of Fatigue in Respiratory Muscles/ Chest.
Vague Discomfort in the Chest.
Sense of Suffocation / Chocking.
Undue Awareness of Breathing.
Abnormal Form of Breathing.
SEVERITY
Present at rest Exertional Spontenaneous.
Mridu - good functional ability.
Daruna- poor functional ability/ confined to bed.
Madhyama- disturbed functional ability.
Develops with gentle activities (undressing, walking on plain ground).
Develops during moderate exertion (climbing the stairs).
Develops during strenuous exercise.
Disturbed sleep due to Dyspnoea.
Functionally fit.
AGGRAVATING FACTORSAbhashyandi aahara Sleshmavarodha Sheeta Ambupana Sheeta Vata sevana Dhuma Raja Manasodvega Vegadharana Meghachadhana Nisha samaya Nidra Shayanavastha Allergens Drugs Followed by bout of coughing. RELIEVING FACTORS Asine sukhanubhava Oushadhi. Sheetopachar Sleshma nisthevana. Ushnapana Vishrana. ASSOCIATED FACTORS Jwara, Arti, Angamarda, Ruja, Lalata Sweda, Kampa, Kantha-Udhwamsa, Kasa, Pratishya, Mutra Daha, Mutrarodha, Vikrita Anana, Urdhva Dristhi, Vibhranta Lochana. Disturbed mentality, Fainting, Loss of consciousness, Wheezing, Chest Pain, Palpitation, and Perspiration. SEASONAL VARIATIONSheeta kale vriddhi Varsha kale vriddhi Aniyamita. Non seasonal non specific. KASA DURATION: . Days/ Weeks/ Months/ Year. MODE OF ONSET Shigrotpatti Chirotpatti Ashukari Chirakalasthi. COURSE Nirantara Santara Savegan Progressive. Duration of episode. Symptom free period.
TYPE Shushka, Ardra, Bhinna, Kamsyopam Dwhani. Short, Paroxysmal, Metallic, Brassy, Bovine, Hoarseness, Harsh. TIMEOn rising in the morning Going to the bed at night Change in the lying posture Nocturnal Non specific SEVERITY Tamo darshana. Jyoti darshana. Maha vega kasa (expulsive). Maha dwhani kasa (loud). Kshobha. Moha. Fainting. Vomiting. Exhaustion. AGGRAVATING FACTORS Cold food articles. Allergens and pollutants. Change in climate and atmosphere. RELIEVING FACTORS Kapha nisthevana. Snigdha aahara. Amla aahara. Ushna aahara. SEASONAL VARIATION Sheeta kale vriddhi. Varsha kale vriddhi. Aniyamita. Non seasonal. Non specific. ASSOCIATED WITH: Hrit shula, shira shula, parshwa shula, prista graha, katigraha, parvabheda, kantha
ruk. Swara bheda, ura shushkata, kantha shushkata, pinasa, svasa, santapa,
trishna, daha, moha, bhrama, gourava, dourbalya, krishata, tiktasyata, aruchi,
mandagni, chardi, utklesha.
URASHULA Duration: . . Days/ week/ month/ year. MODE OF ONSET Sudden, gradual, insidious, episodic. SITE Mid sternal, sub sternal, sub mammary, precordial, left inframammary, left supramammary, spinal, breast, axillary. TYPE Sharp, dull, pressing, constricting, pricking, heaviness, burning, boring, deep, superficial, synchronous to heart beat, related to respiration. RADIATION Shoulder, tip of shoulder, arm, neck, along the course of intra costal nerve, back abdomen.
AGGRAVATING / PRECIPITATING FACTORS Effort, excitement, fatigue, over eating, empty stomach, food intake, recumbency,
swallowing, coughing, sneezing, straining, breathing, twisting the trunk, lying on the
affected side, muscular contraction.
RELIEVING FACTORS
Rest, sitting posture, food intake, vomiting, breath holding, muscle relaxants,
sub lingual nitrates, analgesics.
ASSOCIATED WITH:
Palpitation, perspiration, dyspnoea, fatigue, haemoptysis, emaciation.
SPUTUM:
MOUNT: Bahu/ alpa . . Ml/ 24 hours.
CHARACTER: snigdha, ghana, tanu, grathita, kuthita, puyamaya.
COLOR: Pita, samishra, harita, lohita, shweta shava, shonita.
ODOUR: Nirgandha, durganhi, lohagandhi, visragandha.
TASTE:
BROUGHT OUT BY: Cough, vomiting, clearing the throat.
JWARA:
DURATION: . . Days/weeks/ months.
MODE OF ONSET:
Sudden, insidious, gradual, step ladder fashion, recurrent.
TYPE:
Continuous, remittent, quadition, tertian, quatrain, irregular.
SEVERITY:
Mild, moderate, severe.
DIFERVESCENCE:
Crisis, lysis.
ASSOCIATED WITH:
Rigor, chills, convulsions, delirium, headache, body ache, anorexia.
CHIKATSANUKRAMINIKA VRATTANTA:
PURVA VYADHI VRATTANTA:
KULA VRATTANTA:
VRATTANTA FOR ANURJATA:
ATURA CHARYA
AAHARA Veg/non-veg/mixed: Quantity of food: Frequency of intake: Particulars of the food items: Specific food item (if any), leads to the disorder or aggravates the symptoms:
JALAPANA
Type: source: Purified/Unpurified Chlorinated/non chlorinated:
VIHARA
Nature of work: Laborious Strenuous Sedated Exercise: Indulgence in any out door games:
NIDRA Regular/Irregular Sound Sleep/Disturbed Day/Hours: Night/Hours:
MALA Prakrita Malabaddhata Atipravratti Pramana: Sankhya: Vedana:
MUTRA Prakrita Alpa Atipravratti Pramana: Day/ Night: Sankhya: Day/ Night: Vedana:
SWEDA Prakrita Alpa Atipravratti Day: Night: Perspiration with dyspnoea (nocturnal)
VYASANAS
Smoking: Tobacco chewing: Alcoholism:
Narcotics:
MENSTRUATION Menarche: Menopause: Issues: Miscarriages/Abortions:
PLACE: (Residence)
Condensed: Free Spacious: Dry: Humid: Cold: Warm: Hygienic: Unhygienic: Any other specific conditions:
PLACE: (Working)
Condensed: Free Spacious: Dry: Humid: Cold: Warm: Hygienic: Unhygienic: Any other specific conditions: Clothing: Beddings:
GENERAL EXAMINATION Body Structure: Body Strength: Height: Weight: Blood Pressure: Pulse: Respiration: Temperature: Face: Lips:
SYSTEMIC EXAMINATION GI TRACT
Inspection: Palpation:
Percussion: Auscultation: Others:
CARDIOVASCULAR SYSTEM
Inspection: Palpation: Percussion: Auscultation: Others:
CNS/NEUROLOGICAL SKELETAL/MOTOR FUNCTIONS URO-GENITAL SYSTEM
RESPIRATORY SYSTEM INSPECTION: Shape, Size of the chest
Rate, Rhythm and type of respiration. A] ANTERIOR: 1. 2. Size 3. Shape 4. Symmetry 5. Respiratory movements 6. Swellings and pulsation 7. Drooping of the shoulders B] POSTERIOR:
1. 2. Curvature of the spine [scoliosis] 3. Distance of the spine from either scapulae
C] EITHER SIDES OF THE CHEST: 1. 2. Anterioposterior curvature [kyphosis or lordosis] 3. Anterioposterior diameter or depth. D] UPPER PART OF THE CHEST:
1. 2. Diminution or delay of respiratory excursion. 3. Retraction or flattening of chest [unilateral/bilateral]
E] Movements of the sub costal angle F] Action of the accessory muscles of respiration. G] Position of apical thrust. H] Diaphragmatic movements. PALPATION A] Respiratory movements [expansion of upper, middle lower zones] B] Diaphragmatic movements C] Mediastinal position D] Apex impulse E] Position of trachea F] Tracheal descent with inspiration G] tactile vocal fremitus H] localized swelling I] Localized tenderness J] Crepitus K] Rhoncial fremitus L] Palpable rales M] Friction fremitus N] Lymph node enlargement O] Jugular notch P] Laryngeal fixation Q] Fluctuation of the trachea PERCUSSION 1] Apical percussion 2] Basal percussion 3] Percussion of mediastanum. AUSCULTATION 1] Intensity/loudness 2] Quality/character
(rustling, breezy, blowing, tubular) 3] Comparison between inspiratory and expiratory elements of sounds.
(intensity, duration, length, pitch) 4] Pause in-between inspiration and expiration (present/absent). 5] Other characters. 6] ADDED SOUNDS. A] WHEEZES (RHONCI), Inspiratory/Expiratory. 1] Monophonic [fixed/random] 2] Stridor 3] Polyphonic [expiratory polyphonic, sequential inspiratory wheezes] B] CRACKLES (RALES, CREPITATIONS)
1] Early inspiratory crackles. 2] Late inspiratory crackles. 3] Basal crackles 4] Expiratory crackles. C] Crackle-wheeze. D] Coarse rales (bubbling rales) E] Fine rales (crackling rales,) F] Medium rales G] Post-tussive rales H] Tracheal rales I] Pleural rub J] Vocal sounds (vocal resonance) K] Spoken voice sounds. increased/decreased/absence) L] Whispered voice sounds.
ASTHAVIDHA PAREEKSHA
Nadi: Shabda: Mutra: Sparsha: Mala: Drik: Jheewa: Akriti:
DASHAVIDHA PAREEKSHA Prakritatha: Satmyatatha: Vikritatha: Satwatha: Saratatha: Aahara Shaktitha: Samvahanatha: Vyayama Shaktitha: Pramanatha: Vayatha:
SAMPRAPTHI GHATAKAS
Dosha: Dushya: Srotas: Dusthi: Rogamarga: Adhisthana: Utpattisthana: Vyaktha Sthana:
AGNI Sama Manda Teekshna Vishma KOSTHA Mrudu Madhya Krura
INVESTIGATIONS
BLOOD: HB%, TLC/DLC, ESR, AEC. URINE: Routine SPUTUM: AFB, Eosonophils. CHEST X-RAY, ECG, Pulmonary Function Test
NIDANA PANCHAKAS Hetu: Purva Roopa: Roopa: Upashaya/Anupashaya: Samprapthi: Sambhavya Vyadhis: Sapeksha Nidana: Vyadhi Vineschaya: Upadravas: Aristha Laxanas: Sadhyasadhyata:
GRADING FOR THE ASSESSEMENT OF SEVERITY OF TAMAKA SVASA (Bronchial Asthma)
Scorings Prakrata (1) Mridu (2) Madhyama
(3) Daruna (4)
Assessment for
Svasakrichrata Attack per week
Attack free One attack 2-4 attacks More than 4 attacks
Svasakrichrata Duration
Attack free Brief for minutes
Prolonged for 2-3 hours
Almost continuous
Kasa Absent Relieved by expectoration
Relieved by treatment
Persistent
Svasakrichrata (on speech)
Normal speech
Speaks in sentences for short period
Speaks in phrases or partial sentences
Speaks only in single words or short phrases
Dhur-dhuraka Wheeze absent
End expiratory wheeze only
Wheeze during entire expiration and inspiration
Breath sounds becoming inaudible/ silent chest
Nidra Normal Difficult in getting sleep
Disturbed at the time of attacks
Disturbed at the time of attacks (Frequent)
Vyayama Normal Perform lightly
Reduced Unable
Prajna Normal Varied Confused Loss of consciousness
PEFR More than 90% predicted
70-90% predicted
50-70% predicted
Less than 50% predicted
MEASUREMENT OF VARIABLES (TAMAKA SVASA).
INSTRUCTIONS:
A] Every morning patient has to write, in the squares for each symptom, how he
is feeling, using the following scores.
SLNO SYMPTOMS/COMPLAINTS SCORES 1 Prakrata 0 2 Mridu 1 3 Madhyama 2 4 Daruna 3 B] One has to add up the symptom scores to observe the progress. C] Following symptoms to be observed for scorings.
SVASAKRICHRATA (attacks/week) SVASAKRICHRATA (duration) SVASAKRICHRATA (on speech) KASA DHUR-DHURAKA NIDRA VYAYAMA PRAJNA
ASSESSMENT OF LAB INVESTIGATIONS: INVESTIGATION BEFORE
TREATMENT AFTER TREATMENT
AFTER FOLLOW UP
TC DC ESR AEC Sputum Eosonophils PEFR
ASSESSEMENT OF SEVERITY OF TAMAKA SVASA (Bronchial Asthma)
Assessment of the following variables for there severity in six concluding visits mentioned in the table. SL. no VARIABLES BT AT I W II W III W FU 1. Svasakrichrata
(attacks/ week)
2. Svasakrichrata (Duration )
3. Svasakrichrata (on speech)
4. Kasa 5. Dhur-dhuraka 6. Nidra 7. Vyayama 8. Prajna 9. PEFR BT = Before Treatment AT = After Treatment W = Week FU = end of Follow Up PEFR = Peak Expiratory Flow Rate.
DISSERTATION DETAILS
Title : “A clinical study on the management of
Tamaka shwasa
with special reference to virechana and
Shamana”
Name of Candidate: Dr. Sujata .S.Tenginakai B.A.M.S
Degree Name : M.D. (Ayurveda Vachaspati)
Subject : Kayachikitsa
Name of the Guide: Prof.P.K.Mishra MD (Ay)., (RSU)., Department : Kayachikitsa
College : A.L.N. Rao Memorial Ayurvedic Medical College, Koppa – 577 126
Year : March 2004.